+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 48275

Chapter 48275 contains a list of PDF Full Texts available from EurekaMag.





Sangiorgi, G., 1951:
Anti-lysozyme effect of Niagara sky blue and chlorazol fast pink

Leung, J.C.K.; Chan, L.Y.Y.; Tsang, A.W.L.; Liu, E.W.L.; Lam, M.Fai.; Tang, S.C.W.; Lai, K.Neng., 2004:
Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy

Rothen, M.; Jablon, E.; Monares, G.; Fontal, M.Rodriguez.; Alfaro, D.Virgil., 2005:
Anti-macular degeneration agents

Anonymous, 1952:
Anti-malaria campaign. I. Malaria in French Equatorial Africa

Kalmykov, E.S., 1959:
Anti-malaria measures during various stages of malaria control in the Tadzhik Republic

Hamid, A., 1953:
Anti-malaria scheme for the Lahore Corporation area and its working for the period from 9th July, 1951 to 31st December, 1952

Xu, H.; He, Y.; Yang, X.; Liang, L.; Zhan, Z.; Ye, Y.; Yang, X.; Lian, F.; Sun, L., 2007:
Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes

Farinaud, M.E., 1955:
Anti-malarial campaign and residual spraying with chlorinated insecticides in North Africa

Cervantes Gonzalez, D., 1952:
Anti-malarial campaign in the Cuenca del Tepalcatepec, Michoacan

Morin, H.G., 1955:
Anti-malarial campaign in the years 1953-54 in the Cameroons; preventive measures and preliminary results

Southwell-Sander, G.; Heng-Jooithye, J., 1953:
Anti-malarial drainage in the Naval Base and Establishments, Singapore

Haas, W.R., 1955:
Anti-malarial drugs in flying personnel

Sabaneev, S.N., 1952:
Anti-malarial requirements in construction of water reservoirs in the collective farm

Engers, H.D., 2006:
Anti-malarial vaccination today

Berry, J.A., 1962:
Anti-malarials

Collins, D.C., 1961:
Anti-malignancy factors apparently present in organically grown foods

Munro-Leighton, C.; Blue, E.D.; Gunnoe, T.Brent., 2006:
Anti-markovnikov N-H and O-H additions to electron-deficient olefins catalyzed by well-defined Cu(I) anilido, ethoxide, and phenoxide systems

Chen, M.; Wang, Y-yu.; Zhao, M-hui., 2004:
Anti-mesangial cell autoantibodies and their target antigens in lupus nephritis

Forseberg, R.T., 1963:
Anti-metabolite-metabolite intra-arterial chemotherapy

Ninomiya, I.; Terada, I.; Yoshizumi, T.; Takino, T.; Nagai, N.; Morita, A.; Fushida, S.; Nishimura, G.; Fujimura, T.; Ohta, T.; Miwa, K., 2004:
Anti-metastatic effect of capecitabine on human colon cancer xenografts in nude mouse rectum

Pan, J-ping.; Weng, Y-song.; Wu, Q-qian., 2007:
Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis

Krüger, A.; Krebs, T.; Banke, I.J., 2007:
Anti-metastatic effects of serine protease inhibitors: animal models for analysis

Rana, S.; Rawat, J.; Misra, R.D.K., 2006:
Anti-microbial active composite nanoparticles with magnetic core and photocatalytic shell: TiO2-NiFe2O4 biomaterial system

Kulkarni, A.R.; Kulkarni, V.H.; Keshavayya, J.; Hukkeri, V.I.; Sung, H-Wen., 2005:
Anti-microbial activity and film characterization of thiazolidinone derivatives of chitosan

Brading, M.G.; Cromwell, V.J.; Jones, N.M.; Baldeck, J.D.; Marquis, R.E., 2004:
Anti-microbial efficacy and mode of action studies on a new zinc/ Triclosan formulation

Alvarez, C.; Cortes, J.; Arango, A.; Correa, C.; Leal, A., 2006:
Anti-microbial resistance in intensive care units in Bogotá, Colombia, 2001-2003

Maeda, K.; Mikasa, K., 2003:
Anti-microbial sensitivities of bacteria isolated from patients with chronic lower respiratory tract infection under long-term macrolide therapy

Sheehan, C.; Chew, N., 2006:
Anti-microbial stewardship for urinary tract infection

Muschenheim, C., 1950:
Anti-microbial therapy in pulmonary tuberculosis: medical aspects

Robins, A.B., 1962:
Anti-microbial treatment of pulmonary-tuberculosis in non-hospitalized patients over 55 years of age in New York City

Alhaja, E.; Adan, J.; Pagan, R.; Mitjans, F.; Cascalló, M.; Rodríguez, Mè.; Noé, V.; Ciudad, C.J.; Mazo, A.; Vilaró, Sén.; Piulats, J., 2005:
Anti-migratory and anti-angiogenic effect of p16: a novel localization at membrane ruffles and lamellipodia in endothelial cells

Citron, A.F.; Chein, I.; Harding, J., 1950:
Anti-minority remarks, a problem for action research

Tian, Y.; Li, C-pin., 2007:
Anti-mite activities of 25 kinds of traditional Chinese medicines for Demodex folliculorum

Bogdanos, D-Petrou.; Liaskos, C.; Rigopoulou, E.I.; Dalekos, G.N., 2006:
Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen

Chabert, P.; Fougerousse, Aé.; Brouillard, R., 2006:
Anti-mitotic properties of resveratrol analog (Z)-3,5,4'-trimethoxystilbene

Dat-Xuong, N.; Duchene-Marullaz, M.; Vacher, J.; Buu-Hoi, N.P., 1962:
Anti-monoamine oxidase activity of various nicotinyl- and isonicotinylhydrazine derivatives

Inoshima, I.; Kuwano, K.; Hamada, N.; Hagimoto, N.; Yoshimi, M.; Maeyama, T.; Takeshita, A.; Kitamoto, S.; Egashira, K.; Hara, N., 2004:
Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice

Kitamoto, S.; Egashira, K., 2004:
Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases

Tremellen, K.P.; Kolo, M.; Gilmore, A.; Lekamge, D.N., 2005:
Anti-mullerian hormone as a marker of ovarian reserve

Fréour, T.; Mirallié, S.; Colombel, A.; Bach-Ngohou, K.; Masson, D.; Barrière, P., 2006:
Anti-mullerian hormone: clinical relevance in assisted reproductive therapy

Okay, T.Suely., 2003:
Anti-mullerian hormone: importance in pediatric practice

Wang, D-qing.; Tian, Y-ping.; Song, S-zhen.; Wang, L., 2004:
Anti-mutagenesis effects of total flavonoids of Astragalus

Todoroff, T., 1962:
Anti-mycobacterial drugs in association with proteolytic enzymes in teh therapy of pulmonary tuberculosis

Pana, C.; Perelli, A., 1960:
Anti-mycobacterium drugs and the healing of tuberculous lesions

Polman, C.H.; Killestein, J., 2006:
Anti-myelin antibodies in multiple sclerosis: clinically useful?

Reder, A.T.; Oger, J.J., 2004:
Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis

Steck, A.J.; Stalder, A.K.; Renaud, S., 2006:
Anti-myelin-associated glycoprotein neuropathy

Hsieh, S.C.; Yu, H.S.; Cheng, S.H.; Li, K.J.; Lu, M.C.; Wu, C.H.; Tsai, C.Y.; Yu, C.L., 2006:
Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 antibodies leading to activation-induced cell death of the neutrophils

Pradhan, V.D.; Badakere, S.S.; Pawar, A.R.; Almeida, A.F., 2003:
Anti-myeloperoxidase antibodies in patients with microscopic polyangiitis

Ballinas-Vedugo, M.A.; Alejandre-Aguilar, R.; Aranda-Fraustro, A.; Reyes, P.A.; Monteon, V.M., 2003:
Anti-myosin autoantibodies are more frequent in non-Chagasic cardiomyopathy than in Chagasic cardiomyopathy patients

van Rooij, I.A.J.; Tonkelaar, I.den.; Broekmans, F.J.M.; Looman, C.W.N.; Scheffer, G.J.; de Jong, F.H.; Themmen, A.P.N.; te Velde, E.R., 2004:
Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition

Stubbs, S.A.; Hardy, K.; Da Silva-Buttkus, P.; Stark, J.; Webber, L.J.; Flanagan, A.M.; Themmen, A.P.N.; Visser, J.A.; Groome, N.P.; Franks, S., 2005:
Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries

Xu, J-Jie.; Yao, K.; Yu, C-Jie.; Chen, X.; Lu, M-Ping.; Ding, C-Lin.; Sun, H.; Li, B-Zhou., 2006:
Anti-nasopharyngeal carcinoma effect in vivo and in vitro of cytotoxicity T lymphocyte induced by Ad5-latent membrane protein 2A

Di Carlo, V., 1958:
Anti-nematode action of tetracycline

Rocchietta, S., 1952:
Anti-neoplastic action of podophyllin

Treuherz, W., 1953:
Anti-neoplastic action of superheated vapors of ether, balsoform, chloroform, ethylene dichloride and ethylene trichloride in rats

Vodolazskaya, N.A., 1961:
Anti-neoplastic activity of certain sarcolysin derivatives and related compounds

Urbanski, T.; Gurne, D.; Slopek, S.; Mordarska, H.; Mordarski, M., 1960:
Anti-neoplastic activity of tetrahydro-1, 3-oxazine derivatives

Ji, Y-Bin.; Gao, S-Yong.; Ji, H-Rui.; Kong, Q.; Zhang, X-Juan.; Yang, B-Feng., 2004:
Anti-neoplastic efficacy of Haimiding on gastric carcinoma and its mechanisms

Josserand, A., 1953:
Anti-neoplastic role of certain adrenal cortex hormones

Oku, N.; Asai, T.; Watanabe, K.; Kuromi, K.; Ogino, K.; Taki, T., 2003:
Anti-neovascular therapy by use of liposomes targeted to angiogenic vessels

Giovannoni, G., 2005:
Anti-neuronal antibodies and movement disorders

Posner, J.B., 2004:
Anti-neuronal antibodies in patients with cancer

Oide, T.; Tokuda, T.; Yazaki, M.; Watarai, M.; Mitsuhashi, S.; Kaneko, K.; Hashimoto, T.; Ohara, S.; Ikeda, S-ichi., 2003:
Anti-neuronal autoantibody in Hashimoto's encephalopathy: neuropathological, immunohistochemical, and biochemical analysis of two patients

Klusa, V.; Klimaviciusa, L.; Duburs, G.; Poikans, J.; Zharkovsky, A., 2006:
Anti-neurotoxic effects of tauropyrone, a taurine analogue

Dorlöchter, L.; Carlsson, M.; Olafsdottir, E.J.; Røksund, O.D.; Rosendahl, K.; Fluge, G., 2004 :
Anti-neutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis

Pradhan, V.; Badakere, S.S.; Shankarkumar, U.; Iyer, Y.S.; Ghosh, K.; Karnad, D., 2003:
Anti-neutrophil cytoplasmic antibodies (ANCA) in malaria

Pradhan, V.D.; Badakere, S.S.; Bichile, L.S.; Almeida, A.F., 2005:
Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies

Edington, F.Luiz.Barros.; Bacellar, M.Olívia.Amado.Ramos.; Machado, P.Roberto.; Barbosa, Lúcio.; Reis, E.; Reis, M.; Santiago, M.Barreto., 2006:
Anti-neutrophil cytoplasmic antibodies in leprosy

Tur, B.Sonel.; Süldür, N.; Ataman, S.; Tutkak, Hüseyin.; Atay, M.Birol.; Düzgün, Nşen., 2004:
Anti-neutrophil cytoplasmic antibodies in patients with rheumatoid arthritis: clinical, biological, and radiological correlations

Gisbert, J.P.; Luna, M.; Legido, Jús.; Hermida, C.; Maté, Jé.; Pajares, Jé.María., 2004:
Anti-neutrophil cytoplasmic antibodies in the diagnosis of ulcerative colitis and Crohn's disease

Sugimoto, T.; Koyama, T.; Kanasaki, K.; Morita, Y.; Yokomaku, Y.; Deji, N.; Tanaka, Y.; Uzu, T.; Kashiwagi, A., 2006:
Anti-neutrophil cytoplasmic antibodies-related necrotising crescentic glomerulonephritis in a patient with rheumatoid arthritis

Chan, B.; d'Intini, V.; Savige, J., 2006:
Anti-neutrophil cytoplasmic antibody (ANCA)-associated microscopic polyangiitis following a suppurative wound infection

Suzuki, K., 2006:
Anti-neutrophil cytoplasmic antibody MPO-ANCA related with disease activity of vasculitis

Jones, G.L.; Kingdon, E.J.; Burns, A.P., 2003:
Anti-neutrophil cytoplasmic antibody and a pelvic mass

Miyata, N.; Kobayashi, T.; Matsukawa, Y.; Sawada, S.; Nishinarita, S.; Horie, T., 2003:
Anti-neutrophil cytoplasmic autoantibody-associated rapid progressive glomerulonephritis complicated with both limited and diffuse scleroderma

Przybylski, G.; Gołda, R.; Pyskir, J.; Pasińska, M.; Ludwikowski, G.; Kuziemski, A.; Kopiński, P., 2007:
Anti-nicotine education applied in relation of parents of the diseased children on chronic allergic diseases of respiratory system

Cerny, T., 2005:
Anti-nicotine vaccination: where are we?

Hazard, R.; Beauvallet, M.; Giudicelli, R.; Chabrier, P.; Najer, H., 1955:
Anti-nicotinic action of certain new local anesthetics

Vongtau, H.O.; Abbah, J.; Ngazal, I.E.; Kunle, O.F.; Chindo, B.A.; Otsapa, P.B.; Gamaniel, K.S., 2003:
Anti-nociceptive and anti-inflammatory activities of the methanolic extract of Parinari polyandra stem bark in rats and mice

Nwafor, P.A.; Okwuasaba, F.K., 2003:
Anti-nociceptive and anti-inflammatory effects of methanolic extract of Asparagus pubescens root in rodents

Yoshimura, M.; Furue, H.; Ito, A., 2005:
Anti-nociceptive effect of calcitonin on chronic pain associated with osteoporosis

Girija, K.; Reddy, M.Kannappa.; Viswanathan, S., 2003:
Anti-nociceptive effect of synthesized di-hydroxy flavones: possible mechanism

Guarino, A.; Mazza, V.; Boccalatte, F.; Colicchio, G., 1962:
Anti-normal lung serum and anti-silicotic anti-lung serum

Guarino, A.; Mazza, V.; Boccalatte, F.; Colicchio, G., 1962:
Anti-normal lung serum and anti-silicotic lung serum

Lima, A.O.; Fraga, C.; Seabra, O., 1961:
Anti-nuclear antibodies in systemic lupus erythematosus and in other diseases

Chieregato, G.C., 1962:
Anti-nuclear factors in erythematosus

Fournel, S.; Muller, S., 2003:
Anti-nucleosome antibodies and T-cell response in systemic lupus erythematosus

González, Cón.; Garcia-Berrocal, B.; Herráez, O.; Navajo, Jé.Alejandro.; González-Buitrago, Jé.Manuel., 2004:
Anti-nucleosome, anti-chromatin, anti-dsDNA and anti-histone antibody reactivity in systemic lupus erythematosus

Ashida, H.; Furuyashiki, T.; Nagayasu, H.; Bessho, H.; Sakakibara, H.; Hashimoto, T.; Kanazawa, K., 2005:
Anti-obesity actions of green tea: possible involvements in modulation of the glucose uptake system and suppression of the adipogenesis-related transcription factors

Freemark, M.; Kiess, W., 2006:
Anti-obesity medication use in adolescents: risks and benefits

Powles, T.J., 2003:
Anti-oestrogenic chemoprevention of breast cancer-the need to progress

La, L.; Rao, J-jun.; Wu, S-guang., 2004:
Anti-oncogene p53-induced expression of secreted frizzled-related protein, a Wnt signaling inhibitor

Ueda, H., 2004:
Anti-opioid systems in morphine tolerance and addiction--locus-specific involvement of nociceptin and the NMDA receptor

Cohen, D.P., 2003:
Anti-osteoporotic medications: traditional and nontraditional

Monnier-Barbarino, P.; Jouan, C.; Dubois, M.; Gobert, B.; Faure, G.; Béné, M.C., 2003:
Anti-ovarian antibodies and in vitro fertilization: cause or consequence?

Cavalli, P.; Candotti, G.; Boselli, G., 1960:
Anti-ovulatory activity of 6 alpha-methyl 17 alpha-hydroxyprogesterone acetate determined by the Doyle tes-tape method

Andreoli, C., 1961:
Anti-ovulatory steroids, active by oral route

Andreoli, C., 1961:
Anti-ovulatory steroids; action in oral administration

Bećarevic, M.; Andrejević, S.; Bonaci-Nikolić, B.; Obradović, I.; Miljić, P.; Majkić-Singh, N., 2005:
Anti-oxLDL antibodies--marker for arterial thromboses in antiphospholipid syndrome?

Naderi, G.Ali.; Asgary, S.; Sarraf-Zadegan, N.; Shirvany, H., 2003:
Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation

Ding, S-ju.; Li, J-si., 2006:
Anti-oxidant effects of Tongxinluo on ATPase in focal brain ischemia-reperfusion rats

Sugishita, K.; Li, F.; Su, Z.; Barry, W.H., 2003:
Anti-oxidant effects of estrogen reduce [Ca2+]i during metabolic inhibition

Nakagami, H.; Tomita, N.; Kaneda, Y.; Ogihara, T.; Morishita, R., 2006:
Anti-oxidant gene therapy by NF kappa B decoy oligodeoxynucleotide

Ece, A.; Atamer, Y.; Gürkan, F.; Bilici, M.; Koçyiğit, Yüksel., 2005:
Anti-oxidant status in relation to lipoproteins, leptin and pro-inflammatory cytokines in children with steroid-sensitive nephrotic syndrome

Maxwell, S.R., 1997:
Anti-oxidant therapy: does it have a role in the treatment of human disease?

Armstrong, S.C., 2004:
Anti-oxidants and apoptosis: attenuation of doxorubicin induced cardiomyopathy by carvedilol

Dal Brollo, F.; Polasek, G.; Rigamonti, S., 1958:
Anti-oxidants in the pharmaceutical field: their action on oleaginous solutions of vitamin A. III

Pin, P., 1955:
Anti-oxidation effect vitamin E

Miwa, S.; Watada, H.; Omura, C.; Takayanagi, N.; Nishiyama, K.; Tanaka, Y.; Onuma, T.; Kawamori, R., 2005:
Anti-oxidative effect of fluvastatin in hyperlipidemic type 2 diabetic patients

Okumura, M.; Iwai, M.; Horiuchi, M.; Ito, M., 2006:
Anti-oxidative effects of anti-hypertensive drugs

Chin, B.S.P.; Langford, N.J.; Nuttall, S.L.; Gibbs, C.R.; Blann, A.D.; Lip, G.Y.H., 2003:
Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure

Chen, X-ling., 2004:
Anti-oxygenation effect of procyanidins in plant medicine

Shimanovich, I.; Rose, C.; Hirako, Y.; Butt-Dörje, E.; Zillikens, D., 2005:
Anti-p200 pemphigoid--a new bullous autoimmune dermatosis

Dilling, A.; Rose, C.; Hashimoto, T.; Zillikens, D.; Shimanovich, I., 2007:
Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease

Mocci, F.; De Biasio, A.L.; Nettuno, M., 2004:
Anti-p53 antibodies as markers of carcinogenesis in exposures to vinyl chloride

Mimura, Y.; Yazawa, N.; Tamaki, Z.; Ashida, R.; Jinnin, M.; Asano, Y.; Tada, Y.; Kubo, M.; Ihn, H.; Tamaki, K., 2006:
Anti-p53 antibodies in patients with dermatomyositis/polymyositis

Theobald, M.; Offringa, R., 2004:
Anti-p53-directed immunotherapy of malignant disease

Debray, C.; Lods, J.C., 1963:
Anti-pancreas antibodies. Their importance in pancreatitis

Dai, M-hua.; He, W.; Zhao, Y-pei.; Xu, C-ping., 2005:
Anti-pancreatic cancer effects of human peripheral gammadeltaT cells in a mouse tumor model

He, Y.; Yang, B.; Ruan, C-Geng., 2005:
Anti-pancreatic cancer immune response induced by K-ras mutated peptide

Boulanger, J-C., 2007:
Anti-papillomavirus vaccine: the dream has come true

Hantz, Sébastien.; Alain, S.; Denis, Fçois., 2005:
Anti-papillomavirus vaccines and prevention of cervical cancer: progress and prospects

Anonymous, 1951:
Anti-parasite campaign in Chile

da Silva, Aé.Ricardo.Araujo.; Nogueira, S.Andries.; Alzeguir, Júlio.Cezar.Laura.; da Costa, M.Célia.Freitas.Leite.; do Nascimento, J.Pereira., 2006:
Anti-parvovirus B19 IgG antibody prevalence in pregnant women during antenatal follow-up and cases of non-immune hydropsis fetalis due to parvovirus B19, in the City of Rio de Janeiro

Tentori, L.; Vivaldi, G., 1953:
Anti-pernicious anemia principle, crude liver extracts and thymine; studies on their activity in experimental macrocytic anemia in rats

Hausmann, K., 1949:
Anti-pernicious substances in urine; investigations in the pathogenesis and treatment of pernicious anemia

Papadakis, S.A.; Babourda, E.C.; Mitsitskas, T.C.; Markakidis, S.; Bachtis, C.; Koukouvis, D.; Tentes, A.A., 2006:
Anti-personnel landmine injuries during peace: experience in a European country

Chedid, L.; Boyer, F., 1958:
Anti-pertussis serum inhibition of consecutive sensitization of Hemophilus pertussis vaccination of mice. I. Resistance to histamine. II. Resistance to endotoxins

Gol'dfarb, D.M.; Broker, T.N., 1959:
Anti-phage properties of certain antibiotics, antiseptics, amino acids & anti-tumor drugs

Miyabe, H.; Ishihara, K.; Kigure, T.; Okuda, K., 2004:
Anti-phagocytic role of surface fibrous structure of an invasive Porphyromonas gingivalis strain

Ullah, G.; Jung, P.; Cornell-Bell, A.H., 2005:
Anti-phase calcium oscillations in astrocytes via inositol (1, 4, 5)-trisphosphate regeneration

Kalashnikova, L.A.; Aleksandrova, E.N.; Novikov, A.A.; Dobrynina, L.A.; Nasonov, E.L.; Sergeeva, E.V.; Berkovskiĭ, A.L., 2005:
Anti-phosphatidylethanolamine antibodies in patients with Sneddon's syndrome

Mitsui, M.; Yamashiro, M.; Yamamoto, T., 2005:
Anti-phosphatidylserine-prothrombin antibody in patients with recurrent abortion and preeclampsia

Hasegawa, M.; Fujimoto, M.; Hayakawa, I.; Matsushita, T.; Nishijima, C.; Yamazaki, M.; Takehara, K.; Sato, S., 2006:
Anti-phosphatidylserine-prothrombin complex antibodies in patients with localized scleroderma

Hristoskova, S.; Holzgreve, W.; Hahn, S., 2004:
Anti-phospholipid and anti-DNA antibodies are not associated with the elevated release of circulatory fetal DNA in pregnancies affected by preeclampsia

Dropiński, J.; Szczeklik, W.; Rubiś, Pł.; Sydor, W.J., 2003:
Anti-phospholipid antibodies and carotid-artery intima-media thickness in young survivors of myocardial infarction

Ghosh, A.; Ghosh, M.; Bhattacharya, S.M., 2006:
Anti-phospholipid antibodies as a cause of recurrent pregnancy loss: a study in Calcutta, India

Nakos, G.; Tziakou, E.; Maneta-Peyret, L.; Nassis, C.; Lekka, M.E., 2005:
Anti-phospholipid antibodies in serum from patients with Guillain-Barré syndrome

Fleming, S.D.; Egan, R.P.; Chai, C.; Girardi, G.; Holers, V.Michael.; Salmon, J.; Monestier, M.; Tsokos, G.C., 2004:
Anti-phospholipid antibodies restore mesenteric ischemia/reperfusion-induced injury in complement receptor 2/complement receptor 1-deficient mice

Leuci, E.; Manenti, L.; Maggini, C., 2007:
Anti-phospholipid antibodies, neuroleptic treatment and cardiovascular morbidity

Gotoh, M.; Matsuda, J., 2005:
Anti-phospholipid antibody (aPL)

Tiesmeier, J.; Schuppert, F., 2005:
Anti-phospholipid antibody syndrome: a case report (interview by Dr. Erik Heintz)

Shoenfeld, Y., 2004:
Anti-phospholipid syndrome from a systemic disease toward the infectious etiology

Govea, J., 1952:
Anti-physiological action of anticoagulants in myocardial infarct

Liu, J.; Gustafsson, A.; Breimer, M.E.; Kussak, A.; Holgersson, J., 2004:
Anti-pig antibody adsorption efficacy of {alpha}-Gal carrying recombinant P-selectin glycoprotein ligand-1/immunoglobulin chimeras increases with core 2 {beta}1, 6-N-acetylglucosaminyltransferase expression

Vaultier, R., 1960:
Anti-plague measures in former times

Metelkin, A.I., 1959:
Anti-plague organization in Prerevolutionary Russia; 60th anniversary of the antiplague laboratory of the USSR

Girard, G., 1953:
Anti-plague serum combined with antibiotics as indicated in hypertoxic forms of plague

Baehni, P.C.; Takeuchi, Y., 2003:
Anti-plaque agents in the prevention of biofilm-associated oral diseases

Leys, D., 2004:
Anti-platelet agents in neurological practice

Orzechowski, H-Dieter., 2003:
Anti-platelet function of human endothelial cells: augmentation by angiotensin-converting enzyme inhibitors?

Revelli, E.; Brizio, P.D., 1958:
Anti-platelet immunological factors in the gynecological field; clinical notes supplemented by experimental findings

Dellon, E.S.; Ringel, Y., 2006:
Anti-platelet therapy and recurrent ulcers: Rethinking rebleeding

De Benedetti, E., 2005:
Anti-platelet treatment in cardiology

Vandergheynst, F.; Ocmant, A.; Sordet, C.; Humbel, R.L.; Goetz, J.; Roufosse, F.; Cogan, E.; Sibilia, J., 2006:
Anti-pm/scl antibodies in connective tissue disease: Clinical and biological assessment of 14 patients

Bird, G.W., 1960:
Anti-pneumococcus type XIV activity of precipitins from Ricinus communis seeds

Pattyn, S.R.; Delville, J.P.; De Bont, A.F., 1958:
Anti-poliomyelitis antibodies in Belgian Congo. III. Serological investigation of the Bukavu Congolese population

Karte, H.; Grafe, A., 1962:
Anti-poliomyelitis effectiveness and tolerance of a new combined vaccine. Aluminum oxide adsorbate vaccine against poliomyelitis, diphtheria and tetanus

Grumbach, R.; Roger, F.; Aymard, B., 1960:
Anti-poliomyelitis vaccination in the infant. Study of simple immunization and immunization with combined vaccines

Bonnet, F.; Lambrechts, A., 1963:
Anti-poliomyelitis vaccination with attenuated live virus

Martin, R.; Roger, F.; Damas, J.P.; Roger, A.; Juillard, P., 1961:
Anti-poliomyelitis vaccination with inactivated virus (Lepine vaccine). Effect of the booster injection on immunization

GERBAUT, P.; de LAVERGNE; LORRAIN, J.; POLGE, F.; GILGENKRANTZ, S.; MATHIEU, J.; JEANDIN, F.; LE MOYNE, M.T., 1960:
Anti-poliomyelitis vaccination. Indications. Methods. Clinical and serological results

Crosnier, 1962:
Anti-poliomyelitis vaccinations. Live vaccines and inactivated vaccines. Respective indications. Current status of the problem

Płonka-Syroka, B., 2003:
Anti-positivist inspiration in European medical historiography in the 20th century

Shih, C-Ru.; Wu, J.; Liu, Y.; Liang, Y-Chih.; Lin, S-Yi.; Sheu, M-Thau.; Lee, W-Sen., 2003:
Anti-proliferation effect of 5,5-diphenyl-2-thiohydantoin (DPTH) in human vascular endothelial cells

Ma, J.; Zhong, M.; Wang, Z-Yuan., 2005:
Anti-proliferation effect of genistein on salivary adenoid cystic carcinoma cell line SACC-83 in vitro

Feng, C-xia.; Li, Q-ming.; Liang, W-wen.; Wei, J., 2006:
Anti-proliferation effect of serum containning WEI KANG NING on gastric cancer MGC-803 cells and its mechanism

Kazimírová, M.; Dovinová, I.; Rolníková, Tézia.; Tóthová, Lívia.; Hunáková, L'ubica., 2006:
Anti-proliferative activity and apoptotic effect of tick salivary gland extracts on human HeLa cells

Cheng, Y-Leung.; Lee, S-Chun.; Lin, S-Zong.; Chang, W-Liang.; Chen, Y-Lin.; Tsai, N-Man.; Liu, Y-Chi.; Tzao, C.; Yu, D-Shyong.; Harn, H-Jyh., 2005:
Anti-proliferative activity of Bupleurum scrozonerifolium in A549 human lung cancer cells in vitro and in vivo

von Bueren, Aé.O.; Shalaby, T.; Rajtarova, J.; Stearns, D.; Eberhart, C.G.; Helson, L.; Arcaro, A.; Grotzer, M.A., 2007:
Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells

Marzouk, M.; Gamal-Eldeen, A.; Mohamed, M.; El-Sayed, M., 2007:
Anti-proliferative and antioxidant constituents from Tecoma stans

Moggs, J.G.; Murphy, T.C.; Lim, F.L.; Moore, D.J.; Stuckey, R.; Antrobus, K.; Kimber, I.; Orphanides, G., 2005:
Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes

Wang, J-bing.; Ge, J.; Liu, B-qian.; Huang, B.; Wei, Y-tao., 2006:
Anti-proliferative effect of herpes simplex virus thymidine kinase gene system on human Tenon capsule fibroblasts in vitro

Chuĭkin, I.A.; Lianguzova, M.S.; Pospelov, V.A., 2006:
Anti-proliferative effect of histone deacetylase inhibitors on murine embryonic stem cells

Yamaguchi, K.; Liggett, J.L.; Kim, N-Cheol.; Baek, S.Joon., 2005:
Anti-proliferative effect of horehound leaf and wild cherry bark extracts on human colorectal cancer cells

Shen, G.; Zhu, H.; Wang, X.; Zhang, Y.; Zhu, Z.; Wang, S., 2003:
Anti-proliferative effects induced by anti-CD4 human/murine chimeric antibody and murine anti-CD4 monoclonal antibody

Ogata, Y.; Matono, K.; Shirouzu, K., 2003:
Anti-proliferative effects of biochemical defense modifier antineoplaston in colorectal carcinoma

Wimmer, N.; Robinson, J.A.; Gopisetty-Venkata, N.; Roberts-Thomson, S.J.; Monteith, G.R.; Toth, I., 2006 :
Anti-proliferative effects of novel glyco-lipid-arsenicals (III) on MCF-7 human breast cancer cells

Bjersing, J.L.; Tarkowski, A.; Collins, L.Vincent., 2005:
Anti-proliferative effects of phosphodiester oligodeoxynucleotides

Bemis, D.L.; Capodice, J.L.; Gorroochurn, P.; Katz, A.E.; Buttyan, R., 2006:
Anti-prostate cancer activity of a beta-carboline alkaloid enriched extract from Rauwolfia vomitoria

Regnault, V.; Boehlen, F.; Ozsahin, H.; Wahl, D.; de Groot, P.G.; Lecompte, T.; de Moerloose, P., 2005:
Anti-protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation

Ambrose, L.R.; Little, M.A.; Nourshargh, S.; Pusey, C.D., 2005:
Anti-proteinase 3 antibody binding to neutrophils as demonstrated by confocal microscopy

Cetinkaya, R.; Odabas, A.R.; Selcuk, Y., 2004:
Anti-proteinuric effects of combination therapy with enalapril and losartan in patients with nephropathy due to type 2 diabetes

Gaudrat, F.; Desse, D.; Coude, M.; Pineau-Vincent, F., 2006:
Anti-prothrombin antibodies assay in patients with a risk of thrombosis

Youn, H.J.; Lakritz, J.; Kim, D.Y.; Rottinghaus, G.E.; Marsh, A.E., 2003:
Anti-protozoal efficacy of medicinal herb extracts against Toxoplasma gondii and Neospora caninum

Carneiro, O., 1952:
Anti-pruriginous effect of antihistamines in chickenpox

Dellson, P., 2007:
Anti-psychiatry, the revenge and empathy

Stark, C.; Jones, J.; Agnew, J.; Hepburn, T., 2003:
Anti-psychotic drug prescribing trends in primary care in Scotland 1994-97

Hui, C.Lm.; Chen, E.Yh.; Kan, C.; Yip, K.; Law, C.; Chiu, C.Py., 2006:
Anti-psychotics adherence among out-patients with schizophrenia in Hong Kong

Anonymous, 2004:
Anti-psychotics worsen mental decline

Bequignon, R.; Vialat, C., 1951:
Anti-rabic vaccinations at the Pasteur Institute in 1949

Faillace De Leon, R., 1959:
Anti-rabies campaign in Guatemala

Boccalandro, C.A.; Esquivel, R.B., 1951:
Anti-rabies dispensary; advance post in control of rabies

Selimov, M.A.; Durasova, M.N.; Rogozina, E.N.; Ratgauz, V.G.; Maiorova, L.I., 1957:
Anti-rabies gamma globulin. I. Obtaining and fractionation of immune antirabies serum

Selimov, M.A.; Kovalevskii, M.F.; Semenova, E.V., 1957:
Anti-rabies gamma globulin. II. Studies on the effectiveness of anti-rabies gamma globulin in experimental animals

Noury, M., 1953:
Anti-rabies therapy in Morocco in 1932-1952

Remlinger, P.; Bailly, J.; Hadji, A., 1954:
Anti-rabies therapy in Tangier in 1953

Charest, G., 1960:
Anti-rabies vaccination

Todorovic, K., 1955:
Anti-rabies vaccination and its preventive value

Bequignon, R.; Vialat, C., 1957:
Anti-rabies vaccination at the Pasteur Institute in 1956

Conwell, D.P.; Fox, J.P.; Gerhardt, P., 1956:
Anti-rabies vaccination of man with HEP Flury virus

Gonzalez Hernandez, J.M., 1953:
Anti-rabies vaccination, with special reference to the method used at the Histo-Bacteriologic and Anti-rabies Vaccination Laboratory of Havana

Andrieu, G., 1961:
Anti-rabies vaccinations at the Centre Hospitalier Regional de Toulouse in 1960

Kirsc, E., 1957:
Anti-rabies vaccinations at the Pasteur Institute of Hanol in 1955

Cortis, J.; Law, I.G., 2005:
Anti-racist innovation and nurse education

Hassouneh, D., 2006:
Anti-racist pedagogy: challenges faced by faculty of color in predominantly white schools of nursing

Jacobus, D.P.; Dacquisto, M.P., 1961:
Anti-radiant drug development

Val'dshtein, E.A., 1962:
Anti-radiation effect of cysteamine in the irradiation of Escherichia coli in the presence of radiation-sensitizing agents--oxygen, air and nitric oxide

Reale, M.; Garaventa, A.; Paoli, G.; Costa, G.; Moretti, E., 1957:
Anti-reactive agents in the treatment of pulmonary tuberculosis

Peces, R., 2003:
Anti-recombinant erythropoietin antibodies

Shen, F.; Wu, M-chao., 2005:
Anti-recurrent therapy after resection of hepatocellular

Goldschvartz, J.M., 1950:
Anti-reflecting laminae

Dragesco, J., 1950:
Anti-reflection treatment in microscopy

Jonnalagadda, S., 2004:
Anti-reflux surgery for Barrett's esophagus?

Trondsen, E.; Bakken, I.Johanne.; Skjeldestad, F.Egil., 2005:
Anti-reflux surgery in Norway

Horstmann, R.; Gregor, N.; Classen, C.; Röttgermann, S.; Palmes, D., 2006:
Anti-reflux surgery in patients with adequate response to proton pump inhibitors - is there an indication?

Serra, S.; Vacca, G.; Tumatis, S.; Carrucciu, A.; Morazzoni, P.; Bombardelli, E.; Colombo, G.; Gessa, G.Luigi.; Carai, M.A.M., 2003:
Anti-relapse properties of IDN 5082, a standardized extract of Salvia miltiorrhiza, in alcohol-preferring rats

Schreiber, B.; Pokorny, J., 1958:
Anti-renal auto-antibodies in kidney disease in pregnancy

Vestergaard, P., 2005:
Anti-resorptive therapy for the prevention of postmenopausal osteoporosis : when should treatment begin?

Mejías, Aón.; Chávez-Bueno, S.; Ríos, A.María.; Saavedra-Lozano, Jús.; Fonseca Aten, Mónica.; Hatfield, J.; Kapur, P.; Gómez, A.María.; Jafri, H.S.; Ramilo, O., 2004:
Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model

Costa Bertani, G., 1950:
Anti-reticular cytotoxic or Bogomoletz' serum

Germinario, R.J., 2003:
Anti-retroviral protease inhibitors--'a two edged sword?'

Beq, Séphanie.; Bugault, F.; Colle, J-Hervé.; Lambotte, O.; Delfraissy, J-François.; Thèze, J., 2006:
Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7

Corti, M.E.; Palmero, D.J., 2005:
Anti-retroviral treatment in patients with AIDS and mycobacterial diseases

Sommet, A.; Delpierre, C.; Cuzin, L.; Jaafar, A.; Marchou, B.; Massip, P., 2003:
Anti-retroviral treatment interruptions in HIV-infected adults: causes, clinical, immunological and virological consequences

De Salcedo, I., 1959:
Anti-rheum rheumatic effect & metabolic effects of triamcinolone in rheumatoid arthritis: introductory note

Liefmann, R., 1951:
Anti-rheumatic activity of several steroids

Krzymien, H., 1959:
Anti-rheumatic drugs and glucose metabolism

Spinelli, W.B., 1950:
Anti-rheumatic effects of steroids on rheumatic disease

Kelly, M., 1955:
Anti-rheumatic potency of butazolidin in low doses

Tsutani, K.; Igarashi, A., 2005:
Anti-rheumatoid biologics and pharmacoeconomic evaluation

Takeda, I.; Iwadate, H.; Sugisaki, K.; Takahashi, A.; Nogae, S.; Kanno, T.; Kasukawa, R., 2005:
Anti-ribosomal P antibodies are associated with nephritis, vascular thrombosis and lymphocytopenia in patients with systemic lupus erythematosus

Muro, Y.; Tomita, Y., 2005:
Anti-ribosomal-P antibodies in a Sjögren syndrome patient associated with lupus erythematosus

Ohya, H.; Ichikawa, S.; Yokota, S.; Kimura, H.; Nakazawa, A.; Uechi, M.; Shibata, S., 2003:
Anti-rubella virus IgG in urine: epidemiological application of a new enzyme-liked-immunosorbent assay (ELISA)

Takamori, M.; Motomura, M.; Kawaguchi, N.; Nemoto, Y.; Hattori, T.; Yoshikawa, H.; Otsuka, K., 2004:
Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis

Granito, A.; Muratori, L.; Muratori, P.; Guidi, M.; Lenzi, M.; Bianchi, F.B.; Volta, U., 2006:
Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease

Shitak, R.; Sahai, A.K.; Hota, D.; Chakrabarti, A., 2006:
Anti-seizure efficacy of nimodipine in pentylenetetrazole and kainic acid combined seizure models in mice

Crimmins, M.T.; McDougall, P.J., 2003:
Anti-selective aldol reactions with titanium enolates of N-glycolyloxazolidinethiones

Weatherley, D., 1961:
Anti-semitism and the expression of fantasy aggression

Trunk, J.J., 1958:
Anti-semitism; a contribution to its Freudian interpretation

Zhang, J.; Lu, W.; Li, Y.; Wu, J.; Zhang, C., 2005:
Anti-sense RNA inhibits the expression of synaptotagmin II in RBL-2H3 and enhances the exocytosis of lysosomes in RBL-2H3

Zajdel, R.W.; Denz, C.R.; Narshi, A.; Dube, S.; Dube, D.K., 2005:
Anti-sense-mediated inhibition of expression of the novel striated tropomyosin isoform TPM1kappa disrupts myofibril organization in embryonic axolotl hearts

Theurer, K., 1956:
Anti-sensitization as a new method of desensitization

Martinez, M., 1959:
Anti-seroid activity of antimycobacterial compounds; action of isoniazid and cycloserine

Chodera, A., 1962:
Anti-serotonin compounds

Votava, Z.; Lamplova, I., 1959:
Anti-serotonin effect of D-lysergic acid derivatives

Darin, G., 1963:
Anti-shock hibernation in a case of grave postoperative peritonitis. Presentation of a clinical case

Iwu, M.M.; Igboko, O.A.; Onwubiko, H.; Ndu, U.E., 1986:
Anti-sickling Properties of Cajanus cajan: Effect on Haemoglobin Gelation and Oxygen Affinity

Kao, A.H.; Lacomis, D.; Lucas, M.; Fertig, N.; Oddis, C.V., 2004:
Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy

Alaerts, L., 1960:
Anti-smallpox vaccination in keratitis

Mohsin, M., 2006:
Anti-smoking campaign in Multan, Pakistan

Hirsch, A., 2006:
Anti-smoking campaign: scientific basis and perspectives

Ngoan, L.Tran., 2006:
Anti-smoking initiative and decline in incidence rates of lung cancer in Viet Nam

Mazza, R.; Boffi, R.; Ruprecht, A.; Invernizzi, G., 2007:
Anti-smoking legislation: its effects and new challenges

Kegler, M.C.; Malcoe, L.Halinka., 2004:
Anti-smoking socialization beliefs among rural Native American and White parents of young children

Henriksen, L.; Jackson, C., 2005:
Anti-smoking socialization: relationship to parent and child smoking status

Herskovitz, H.H.; Levine, M.; Spivack, G., 1959:
Anti-social behavior of adolescents from higher socio-economic groups

McCALLUM, C.M., 1950:
Anti-social behaviour in adolescents

McCALLUM, C.M., 1950:
Anti-social behaviour in children

Darke, S.; Finlay-Jones, R.; Kaye, S.; Blatt, T., 1996:
Anti-social personality disorder and response to methadone maintenance treatment

Andre, L.; Gallini, A.; Montastruc, Fçois.; Coley, N.; Montastruc, J-Louis.; Vellas, B.; Andrieu, S.; Gardette, V., 2018:
Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study

Vitozzi, S.; Lapierre, P.; Djilali-Saiah, I.; Marceau, G.; Beland, K.; Alvarez, F., 2004:
Anti-soluble liver antigen (SLA) antibodies in chronic HCV infection

Vitozzi, S.; Djilali-Saiah, I.; Lapierre, P.; Alvarez, F., 2003:
Anti-soluble liver antigen/liver-pancreas (SLA/LP) antibodies in pediatric patients with autoimmune hepatitis

Horakova, Z., 1959:
Anti-spastic effect of butynylbarbituric acid derivatives

Halpern, B.N.; Bessis, M., 1950:
Anti-spherocytic action of certain synthetic substances derived from phenothiazine

Steinbuch, M., 1953:
Anti-spherocytic anti-rouleaux and anti-lytic action of some synthetic antihistaminics

Cajano, A.; Giordano, G.G.; Cali, A.; Jacobelli, A.; Maimone, G.; Rossi, G.B., 1958:
Anti-spleen cell-fractions in the guinea pig. IV. Cyto- & histopathological findings in guinea pigs treated with anti-spleen cell-fraction immune sera

Oliva, B.; O'Neill, A.John.; Miller, K.; Stubbings, W.; Chopra, I., 2004:
Anti-staphylococcal activity and mode of action of clofazimine

Galliera, A., 1960:
Anti-staphylolysin titer in the personnel employed in the wards of the Ospedale Civile in Udine

Gupta, M.; Mazumder, U.K.; Pal, D.K.; Bhattacharya, S., 2004:
Anti-steroidogenic activity of methanolic extract of Cuscuta reflexa roxb. stem and Corchorus olitorius Linn. seed in mouse ovary

Gupta, M.; Mazumder, U.K.; Vamsi, M.L.M.; Sivakumar, T.; Kandar, C.C., 2003:
Anti-steroidogenic activity of the two Indian medicinal plants in mice

Levander, S., 2004:
Anti-stigma campaigns: sympathetic but counterproductive

Takahashi, K., 2006:
Anti-stigma--for the freedom from mental barriers

Levander, S., 2004:
Anti-stigmatization campaign--starting at the wrong end

Kim, J.E.; Mathies, R.A., 2006:
Anti-stokes Raman study of vibrational cooling dynamics in the primary photochemistry of rhodopsin

Zhang, Y-liang.; Sun, Z-rong.; Li, Y-qiong.; Ding, L-en.; Wang, Z-geng., 2005:
Anti-stokes blue fluorescence and stark splitting of 3H4 in Pr3+:Y2SiO5 (YSO)

Fernandez, J.; Garcia-Adeva, A.J.; Balda, R., 2006:
Anti-stokes laser cooling in bulk erbium-doped materials

Pakuła, R., 1952:
Anti-streptococcal agglutining in the blood of normal subjects

Faber, V., 1953:
Anti-streptococcal-hyaluronidase I., the turbidimetric method for determination of anti-streptococcal-hyaluronidase in serum

Faber, V., 1953:
Anti-streptococcal-hyaluronidase IV. Comparison of anti-streptococcal-hyaluronidase and anti-streptolysin-O in sera from patients with rheumatic fever, glomerulonephritis, tonsillitis and rheumatoid arthritis

Faber, V., 1953:
Anti-streptococcal-hyaluronidase. II. Turbidimetric determination of anti-streptococcal-hyaluronidase in the sera of normal individuals

Faber, V., 1953:
Anti-streptococcal-hyaluronidase. III. The turbidimetric determination of anti-streptococcal-hyaluronidase (ASH) in sera from patients with rheumatic fever, glomerulonephritis, tonsillitis and rheumatoid arthritis

Sethi, S.; Kaushik, K.; Mohandas, K.; Sengupta, C.; Singh, S.; Sharma, M., 2003:
Anti-streptolysin O titers in normal healthy children of 5-15 years

Zina, G.; Bonu, G., 1955:
Anti-streptolysin titer of the serum in some dermatoses

Ball, W.A., 1963:
Anti-stress

Stoker, J.B.; Stoker, S.B., 1954:
Anti-stress action of heparin on phagocytic activity of leucocytes (in vitro)

Rai, D.; Bhatia, G.; Sen, T.; Palit, G., 2004:
Anti-stress effects of Ginkgo biloba and Panax ginseng: a comparative study

Bernier, D.; Gaston, L., 1982:
Anti-stress intervention with a health and social service clientele.

Valeyre, D., 2004:
Anti-synthetases syndrome

Kose, E.; Hirai, T.; Seki, T.; Hidaka, S.; Hamamoto, T., 2018:
Anticholinergic load negatively correlates with recovery of cognitive activities of daily living for geriatric patients after stroke in the convalescent stage

Ramon, G., 1951:
Anti-tetanus and associated vaccinations

Tasman, A., 1959:
Anti-tetanus immunity

Regamey, R.H.; Schlegel, J.J., 1951:
Anti-tetanus immunity in the ten years following basic immunisation

De Figueiredo, J.M.P.; Souza, C., 1951:
Anti-tetanus serotherapy; statistics

Bernard, J.G.; Laaban, J.; Lechat, S., 1959:
Anti-tetanus vaccination and albuminuria

Cottet, J.; Mathivat, A., 1955:
Anti-therogenic activity of phenyl-ethyl-acetic acid

Verwilghen, R.; Verstraete, M.; Vandenbroucke, J., 1953 :
Anti-thrombin specific antibodies of equine origin; description of a case where such antibodies developed following repeated injections of thrombin

Jonderko, G.; Sroczynski, J., 1959:
Anti-thrombocytic antibodies as a pathogenic factor in chronic idiopathic thrombopenia

Dropinski, J.; Musial, J.; Jakiela, B.; Wegrzyn, W.; Sanak, M.; Szczeklik, A., 2006:
Anti-thrombotic action of clopidogrel and P1(A1/A2) polymorphism of beta3 integrin in patients with coronary artery disease not being treated with aspirin

Lev, E.I.; Patel, R.; Karim, A.; Kleiman, A.; Badimon, J.J.; Kleiman, N.S., 2006:
Anti-thrombotic effect of bivalirudin compared with eptifibatide and unfractionated heparin in diabetic patients: an ex vivo human study

Hayashi, T., 2004:
Anti-thrombotic effect of nitric oxide

Lane, D.; Lip, G.Y.H., 2004:
Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment

Lee, A.Y.Y., 2003:
Anti-thrombotic therapy in cancer patients

Montalescot, G.; Payot, L.; Collet, J-Philippe.; Choussat, Rémi.; Beygui, F., 2005:
Anti-thrombotic therapy of acute coronary syndromes without ST elevation

Helft, G.; Worthley, S.G., 2005:
Anti-thrombotic, anti-platelet and fibrinolytic therapy: current management of acute myocardial infarction

Sprott, W.E.; Wilkinson, J.H.; Maclagan, N.F., 1953:
Anti-throxine effects of n-butyl-4-hydroxy-3-iodobenzoate

Osmer, J.; Jennings, R.B.; Dowben, R.M., 1959:
Anti-thyroid action of beta-aminoethylisothiouronium dibromide in rats

Cheeseman, G.W.; Heikel, T.A.; Knight, B.C.; Rimington, C., 1959:
Anti-thyroid activity of 2-mercaptopyrazine

Hedgley, E.J.; Heikel, T.A.; Knight, B.C.; Rimington, C., 1959:
Anti-thyroid activity of pyridaz-3-thione

Andolfatto-Zaglia, G.; Ziliotto, D., 1961:
Anti-thyroid antibodies in patients undergoing therapy with radioactive iodine

Cheng, W.; Gilliam, A.C.; Castrovinci, A.; Pazirandeh, M., 2006:
Anti-thyroid autoantibody-associated interface dermatitis in individuals with undifferentiated connective tissue disease--an unrecognized subset of autoimmune disease?

Daneshpazhooh, M.; Mostofizadeh G, M.; Behjati, J.; Akhyani, M.; Robati, R.Mahmoud., 2006:
Anti-thyroid peroxidase antibody and vitiligo: a controlled study

Cleroux, A., 1956:
Anti-thyroid substances

Dunlop, D., 1950:
Anti-thyroid substances in the treatment of hyperthyroidism

Giraud, G.; Latour, H.; Levy, A.; Puech, P.; Roujon, J.; Giraud, M.C., 1956:
Anti-thyroid-stimulant pretibial circumscript myxedema

Cho, B.Y.; Choe, S.J.; Koh, C.S.; Lee, M., 1986:
Anti-thyroxine antibodies in autoimmune thyroiditis--effect on radioimmunoassay and binding characteristics

Fernandez-Ruvalcaba, M.; Preciado-De-La Torre, F.; Cruz-Vazquez, C.; Garcia-Vazquez, Z., 2004:
Anti-tick effects of Melinis minutiflora and Andropogon gayanus grasses on plots experimentally infested with Boophilus microplus larvae

Willadsen, P., 2005:
Anti-tick vaccines

Hill, P.G.; McMillan, S.A., 2006:
Anti-tissue transglutaminase antibodies and their role in the investigation of coeliac disease

Unsworth, D.J.; Pitcher, M.C.L.; Stevens, S.; Lock, R.J., 2004:
Anti-tissue transglutaminase antibodies in coeliac disease are not a response to gut damage alone

Tursi, A., 2006:
Anti-tissue transglutaminase in inflammatory bowel diseases: an activity disease-related phenomenon?

Ducos; Broussy, 1957:
Anti-tissular antibodies

Chiauzzi, A., 1955:
Anti-tobacco cigarettes in prevention of cancer; study of the social problem of smoking

Reinert, B.; Carver, V.; Range, L.M., 2005:
Anti-tobacco messages from different sources make a difference with secondary school students

Hyland, A.; Wakefield, M.; Higbee, C.; Szczypka, G.; Cummings, K.M., 2006:
Anti-tobacco television advertising and indicators of smoking cessation in adults: a cohort study

Hamidou, M.A.; Audrain, M.A.; Masseau, A.; Agard, C.; Moreau, A., 2006:
Anti-topoisomerase I antibodies in systemic lupus erythematosus as a marker of severe nephritis

Della Pietra, G.; Capano, V.; De Lorenzo, F.; Rogliani, C., 1959:
Anti-toxic action of glutamic acid, of vitamin B6 and of a combination of glutamic acid and vitamin B6 against the convulsant action and the lethal effects induced by isonicotinic acid hydrazide (INH) in the rat

O'connor, G.R., 1957:
Anti-toxoplasma precipitins in aqueous humor

Tabone, V., 1951:
Anti-trachoma campaign in Gozo

Parfitt, T., 2004:
Anti-trafficking law stalls in Russian parliament. Draft legislation stumbles as state bodies argue over who will lead the anti-trafficking effort

Baldas, V.; Not, T.; Tommasini, A.; Ansaldi, F.; Demarini, S.; Sblattero, D.; Marzari, R.; Torelli, L.; Burlina, A.; Tiribelli, C.; Ventura, A., 2004:
Anti-transglutaminase antibodies and age

Aizawa, M.; Suyama, T.; Irie, M., 1956:
Anti-transplantabilities of the rats immunized against the cells of ascites tumors of rats treated with formol and trichloroacetic acid

Preziosi, P.; De Vleeschhouwer, G.R., 1959:
Anti-tremorine effects of the diethylaminoethylester of monoethyl-phenylethylmalonate

Censuales, S.; Garofalo, V., 1959:
Anti-treponema antibodies in human syphilis detected by the fluorescence test

Safonova, T.V.; Fedianina, L.V.; Trusov, S.N.; Feoktistova, T.S.; Sevbo, D.P.; Mikhaĭlitsyn, F.S., 2004:
Anti-trichuriasis activity of the agents G-1730 and G-1732

McIntire, T., 2006:
Anti-trust implications of independent practice associations

McIntire, T.J., 2006:
Anti-trust implications of independent practice or associations

Johnson, D.E.L., 2005:
Anti-trust suits should be against HMOs

Suri, J.C., 1952:
Anti-tubercular activity of organic (synthetic) compounds related to PAS in vitro

Fernando, A., 1958:
Anti-tuberculin action of gamma globulin; 1st preliminary note

Dekker, T.G.; Lötter, A.P., 2003:
Anti-tuberculosis 4FDC tablets--mystery to chemistry

Casoli, L., 1958:
Anti-tuberculosis BCG vaccination

Sorrentino, F.; Mosca, G., 1955:
Anti-tuberculosis action of calcium methanesulfonate of isonicotinic acid hydrazide; clinical study

Moncalvo, F., 1957:
Anti-tuberculosis action of calcium salt of N-benzoyl-paraaminosalicylic acid

Ward, G.W., 1958:
Anti-tuberculosis activities amongst Indians and Eskimos in Canada

Moczulska, A., 2004:
Anti-tuberculosis activity of some N-pentopyranosylamines

Sah, P.P.; Sah, H., 1958:
Anti-tuberculosis agents derived from 3-ethoxy-4-hydroxybenzaldehyde

Navarro Gutierrez, R., 1950:
Anti-tuberculosis campaigns in rural districts

Belli, M., 1952:
Anti-tuberculosis consultation centers in Italian public health and in reforms performed by CPA in Milano

Senaratne, W.V.; Pinidiyapathirage, M.J.; Perera, G.A.M.H.E.; Wickremasinghe, A.R., 2006:
Anti-tuberculosis drug inducd hepatitis - a Sri Lankan experience

Zhao, S-ying., 2004:
Anti-tuberculosis drug resistance in children and its countermeasure

Swaminathan, S.; Paramasivan, C.N.; Ponnuraja, C.; Iliayas, S.; Rajasekaran, S.; Narayanan, P.R., 2005:
Anti-tuberculosis drug resistance in patients with HIV and tuberculosis in South India

Aragó Galindo, M.; Belda Mira, A.; Albert Contell, A.; Serra Sanchís, B.; Amorós Quiles, I.; Prat Fornells, J.; Escoms Trullenque, R.; González, C., 2006:
Anti-tuberculosis drug resistance of Mycobacterium tuberculosis in the area of the Hospital de Sagunto from 1999 to 2004

Wada, M., 2005:
Anti-tuberculosis drug-induced hepatitis

Doi, N., 2003:
Anti-tuberculosis drugs

Serra, L.M., 1955:
Anti-tuberculosis drugs and BCG

Grandi, F.; Malossi, M., 1958:
Anti-tuberculosis killed vaccines: Salvioli's diffusing vaccine. I. Rationale, basis and trends of anti-tuberculosis vaccination with killed bacteria according to the Maraglino method

Benjamin, P.V., 1955:
Anti-tuberculosis scheme for India

Wallis, R.S., 2005:
Anti-tuberculosis treatment and infliximab

Anonymous, 1952:
Anti-tuberculosis vaccination

Anonymous, 1949:
Anti-tuberculosis vaccination at the Verona Medical Days

Galzerano, G.; Sorrentini, R., 1957:
Anti-tuberculosis vaccination with Mycobacterium muris

Signorini, L.F., 1956:
Anti-tuberculosis vaccination with Petragnani total anatuberculin "C": effect of the vaccine on guinea pigs of various weights

Bethoux, L.; Duny, S., 1959:
Anti-tuberculosis vaccination with high doses of oral BCG in 200 children, of whom 160 were infants of tuberculous parents

Levaditi, C.; Girard, A.; Vaisman, A.; Ray, A., 1952:
Anti-tuberculotic effect of the gamma-pyridine-aldehyde-thiosemicarbazone (G.527), isomer of G. 469

Tarasova, E.F., 1954:
Anti-tuberculous action in rural areas in the Moscow region

Livingstone, J.L., 1957:
Anti-tuberculous drugs

Ikeniwa, A., 1952:
Anti-tuberculous preparations and experimentally produced subcutaneous local immunity

Urbanski, T.; Serafinowa, B.; Gustowski, W.; Venulet, J.; Jakimowska, K.; Janowiec, M., 1960:
Anti-tuberculous properties of ethyl acetoacetate isonicotinoylhydrazone (T-428)

Anonymous, 1951:
Anti-tuberculous stamps, seals and labels

Abraham, S.; Mitchell, A.; Cope, A., 2006:
Anti-tuberculous therapy-induced crystal arthropathy

Goyos, A.; Cohen, N.; Gantress, J.; Robert, J., 2004:
Anti-tumor MHC class Ia-unrestricted CD8 T cell cytotoxicity elicited by the heat shock protein gp96

Larionov, L.F.; Khokhlov, A.S.; Skhodinskaia, E.N.; Vasina, O.S.; Trusheikina, V.L.; Novikova, M.A., 1955:
Anti-tumor action of p-bis (chloroethyl) aminophenylalanine (sarcolysin)

Takamiya, K.; Sumiki, Y., 1957:
Anti-tumor activities of oximes. II

Kravchenko, A.I., 1958:
Anti-tumor activity and toxicity of certain alicylic beta-chlorethylamines in experimental conditions

Tsugu, H.; Onishi, H.; Fukushima, T.; Lee, S., 2007:
Anti-tumor activity of de novo designed small globular protein (SGP) in vivo

Ferrari, W.; Costa, E., 1950:
Anti-tumor activity of fast pink chlorazol. I. Effect of fast pink chlorazol on sarcoma due to benzopyrene and on the growth of grat tumors

Elzaouk, L.; Moelling, K.; Pavlovic, J., 2006:
Anti-tumor activity of mesenchymal stem cells producing IL-12 in a mouse melanoma model

Landriscina, M.; Spadafora, C.; Cignarelli, M.; Barone, C., 2007:
Anti-tumor activity of non-nucleosidic reverse transcriptase inhibitors

Trusheikina, V.I., 1958:
Anti-tumor activity of optic isomers of sarcolysin

Abdi, S., 2006:
Anti-tumor agents for neuropathic pain: switching roles?

Mendoza, F.J.; Espino, P.S.; Cann, K.L.; Bristow, N.; McCrea, K.; Los, M., 2005:
Anti-tumor chemotherapy utilizing peptide-based approaches--apoptotic pathways, kinases, and proteasome as targets

Zhang, C-hu.; Hu, S-yu.; Li, Y-hui.; Cao, M-qun., 2006:
Anti-tumor effect and mechanism of Paeonol on the hepatocellular carcinoma cell line Bel-7404

Shu, X.; Wang, G., 2006:
Anti-tumor effect and mechanism of SEA-Fab' coupled protein on gastric tumor

Koshimune, R.; Aoe, M.; Toyooka, S.; Hara, F.; Ouchida, M.; Tokumo, M.; Sano, Y.; Date, H.; Shimizu, N., 2007:
Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines

Lapidus, R.G.; Dang, W.; Rosen, D.Marc.; Gady, A.M.; Zabelinka, Y.; O'Meally, R.; DeWeese, T.L.; Denmeade, S.R., 2004 :
Anti-tumor effect of combination therapy with intratumoral controlled-release paclitaxel (PACLIMER microspheres) and radiation

Sun, Z-Xiao.; Zhang, Y-Hui.; Cheng, S.; Ma, Q-Wen.; Guo, S-Li.; Zhang, J-Bao., 2005:
Anti-tumor effect of ethanol extracts from Thymus quinquecostatus Celak on human leukemia cell line

Wang, X.; Liu, F.; Li, X.; Li, J.; Xu, G., 2003:
Anti-tumor effect of human endostatin mediated by retroviral gene transfer in nude mice

Okamoto, M.; Ahmed, S.Uddin.; Oshikawa, T.; Tano, T.; Sato, M., 2004:
Anti-tumor effect of intratumoral administration of dendritic cells in combination with TS-1 and OK-432

Kitajima, M.; Tsuyama, Y.; Miyano-Kurosaki, N.; Takaku, H., 2005:
Anti-tumor effect of intravenous TNFalpha gene delivery naked plasmid DNA using a hydrodynamics-based procedure

Dong, L-feng.; Zhang, Y-jun.; Liu, J-sheng.; Song, S-xia.; Hou, J.; Lu, Z-jun., 2006:
Anti-tumor effect of monkshood polysaccharide with adriamycin long circulating temperature-sensitive liposome and its mechanism

Wu, C-Mei.; Li, X-Yi.; Huang, T-Hua., 2004:
Anti-tumor effect of pEgr-IFNgamma gene-radiotherapy in B16 melanoma-bearing mice

Yang, W.; Li, X-yi., 2005:
Anti-tumor effect of pEgr-interferon-gamma-endostatin gene-radiotherapy in mice bearing Lewis lung carcinoma and its mechanism

Ma, H-bing.; Wang, X-jing.; Hu, H-tao.; Di, Z-li.; Xia, H.; Wang, Z.; Li, C.; Han, Z-kai.; Ma, J.; Wu, C-mei., 2005:
Anti-tumor effect of pcDNA3. 1-Egr. 1p-p16 gene combined with radiotherapy in tumor-bearing nude mice

Li, X.; Rong, J.; Wu, M.; Zeng, X., 2003 :
Anti-tumor effect of polysaccharide from Grifola frondosa and its influence on immunological function

Fukuoka, F.; Shirasu, Y., 1961:
Anti-tumor effect of some nitrogen mustard peptides

Satake, K.; Takagi, E.; Ishii, A.; Kato, Y.; Imagawa, Y.; Kimura, Y.; Tsukuda, M., 2003:
Anti-tumor effect of vitamin A and D on head and neck squamous cell carcinoma

Huang, X.; Bennett, M.; Thorpe, P.E., 2004:
Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen

Song, W-gang.; Qu, X.; Li, Y-lin.; Xu, Y-ping.; Wu, C.; Qin, Q-liang., 2004:
Anti-tumor effects of 10-hydroxycamptothecinc-treated DC-Hepa1-6 fusion vaccines

Yano, T.; Taketani, Y., 2006:
Anti-tumor effects of GnRH analogs in gynecological cancers

Zeng, S.; Liu, D.; Ye, Y.; Wang, L.; Wang, W., 2005:
Anti-tumor effects of ampelopsin on human lung cancer GLC-82 implanted in nude mice

Maeda, N.; Kokai, Y.; Ohtani, S.; Sahara, H.; Kuriyama, I.; Kamisuki, S.; Takahashi, S.; Sakaguchi, K.; Sugawara, F.; Yoshida, H.; Sato, N.; Mizushina, Y., 2006:
Anti-tumor effects of dehydroaltenusin, a specific inhibitor of mammalian DNA polymerase alpha

Maruzzella, J.C.; Brenner, D.J., 1963:
Anti-tumor effects of essential oils on crocker sarcoma 180 in mice

Li, J.; Sun, Y.; Masako, C.; Li, F.; Alan, G., 2005:
Anti-tumor effects of mouse factor VII-Staphylococcus enterotoxin A (mfVII) chimeric protein in mice

Tsuyama, Y.; Kitajima, M.; Miyano-Kurosaki, N.; Takaku, H., 2006:
Anti-tumor effects of naked plasmid DNA using a hydrodynamics-based procedure

Yang, Y-li.; Ding, Z-yu.; Li, Q.; Zhou, H.; Deng, H-xin.; Tian, L.; Wei, Y-quan., 2006:
Anti-tumor effects of recombinant adenovirus encoding survivin encapsulated in cationic liposome

Bhatnagar, P.K.; Awasthi, A.; Nomellini, J.F.; Smit, J.; Suresh, M.R., 2006:
Anti-tumor effects of the bacterium Caulobacter crescentus in murine tumor models

Lalani, A.S.; Chang, B.; Lin, J.; Case, S.S.; Luan, B.; Wu-Prior, W-Wei.; VanRoey, M.; Jooss, K., 2004:
Anti-tumor efficacy of human angiostatin using liver-mediated adeno-associated virus gene therapy

Zajchowski, D.A.; Biroc, S.L.; Liu, H-Lai.; Chesney, S.K.; Hoffmann, J.; Bauman, J.; Kirkland, T.; Subramanyam, B.; Shen, J.; Ho, E.; Tseng, J-Lie.; Dinter, H., 2005:
Anti-tumor efficacy of the nucleoside analog 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl) cytosine (4'-thio-FAC) in human pancreatic and ovarian tumor xenograft models

Bi, Y-chun.; Yang, L-jia.; Dong, S-zhong.; Fan, Q-yu.; Zhang, D-zhong., 2005:
Anti-tumor immune response in vitro induced by fusion of Tca8113 cells with macrophages

Xu, J-Jie.; Yao, K.; Yu, C-Jie.; Chen, X.; Lu, M-Ping.; Sun, H.; Li, B-Zhou.; Ding, C-Ning.; Zhou, F., 2006:
Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells

Oshikawa, T.; Okamoto, M.; Ahmed, S.Uddin.; Tano, T.; Sasai, A.; Kan, S.; Sato, M., 2005:
Anti-tumor immunity induced by OK-432-derived DNA

Madoulet, C.; Perrin, L.; Tosi, P.F.; Albert, P., 2006:
Anti-tumor immunotherapy against multidrug resistance

Epaulard, O.; Toussaint, B.; Quenee, L.; Derouazi, M.; Bosco, N.; Villiers, C.; Le Berre, R.; Guery, B.; Filopon, D.; Crombez, L.; Marche, P.N.; Polack, B., 2006:
Anti-tumor immunotherapy via antigen delivery from a live attenuated genetically engineered Pseudomonas aeruginosa type III secretion system-based vector

Fan, Y-zu.; Zhao, Z-ming.; Fu, J-ye.; Chen, C-qiu., 2006:
Anti-tumor mechanism of norcantharidin for the implanted tumors of human gallbladder carcinoma in nude mice in vivo

Edrees, A.F.; Misra, S.N.; Abdou, N.I., 2005:
Anti-tumor necrosis factor (TNF) therapy in rheumatoid arthritis: correlation of TNF-alpha serum level with clinical response and benefit from changing dose or frequency of infliximab infusions

Granado, M.; Priego, T.; Martín, A.Isabel.; Vara, E.; López-Calderón, Aón.; Angeles Villanúa, Mía., 2006:
Anti-tumor necrosis factor agent PEG-sTNFRI improves the growth hormone/insulin-like growth factor-I system in adjuvant-induced arthritic rats

Nakamura, S.; Ohno, S., 2005:
Anti-tumor necrosis factor alpha antibody in the treatment of Behçet's disease

Tse, S.M.L.; Burgos-Vargas, R.; Laxer, R.M., 2005:
Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy

Zaccagna, A.; Bertone, A.; Puiatti, P.; Picciotto, F.; Sprujevnik, T.; Santucci, R.; Rossini, F.Paolo., 2003:
Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease

Favalli, E.Giulio.; Arreghini, M.; Arnoldi, C.; Panni, B.; Marchesoni, A.; Tosi, S.; Pontikaki, I., 2004:
Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis

Khanna, D.; McMahon, M.; Furst, D.E., 2004:
Anti-tumor necrosis factor alpha therapy and heart failure: what have we learned and where do we go from here?

Roos, J.C.P.; Ostor, A.J.K., 2005:
Anti-tumor necrosis factor alpha therapy and the risk of JC virus infection

Symmons, D.P.M.; Silman, A.J., 2004:
Anti-tumor necrosis factor alpha therapy and the risk of lymphoma in rheumatoid arthritis: no clear answer

Gottenberg, J-Eric.; Merle-Vincent, F.; Bentaberry, F.; Allanore, Y.; Berenbaum, F.; Fautrel, B.; Combe, B.; Durbach, A.; Sibilia, J.; Dougados, M.; Mariette, X., 2003:
Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy

Warrington, K.J., 2004:
Anti-tumor necrosis factor alpha therapy in rheumatoid arthritis: hitting two birds with one stone?

Kountouras, J.; Zavos, C.; Chatzopoulos, D., 2005:
Anti-tumor necrosis factor therapy for ulcerative colitis

Hoffman, G.S.; Merkel, P.A.; Brasington, R.D.; Lenschow, D.J.; Liang, P., 2004:
Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis

Momeni, M.; Mehta, A.P.; Katz, J.D., 2005:
Anti-tumor necrosis factor therapy is tolerated in an individual with homozygous complement C2 deficiency

Hyrich, K.L.; Silman, A.J., 2006:
Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety

Gonzalez-Gay, M.A.; De Matias, J.M.; Gonzalez-Juanatey, C.; Garcia-Porrua, C.; Sanchez-Andrade, A.; Martin, J.; Llorca, J., 2006:
Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis

Moore, T.A.; Lau, H.Y.; Cogen, A.L.; Monteleon, C.L.; Standiford, T.J., 2003:
Anti-tumor necrosis factor-alpha therapy during murine Klebsiella pneumoniae bacteremia: increased mortality in the absence of liver injury

Poynard, T.; Thabut, D.; Chryssostalis, A.; Taieb, J.; Ratziu, V., 2003:
Anti-tumor necrosis factor-alpha therapy in severe alcoholic hepatitis: are large randomized trials still possible?

Ivanovska, I.; Muhoro, C.N.; Irusta, P.M., 2006:
Anti-tumor therapeutic molecules that target the programmed cell death machinery

Surh, Y.J.; Park, K.K.; Chun, K.S.; Lee, L.J.; Lee, E.; Lee, S.S., 2004:
Anti-tumor-promoting activities of selected pungent phenolic substances present in ginger

Nau, J-Yves., 2006:
Anti-tumoral properties discovered in a newly discovered dendritic cell subset

Shin, V.Yvonne.; So, W.Hau-Leung.; Liu, E.Shiu-Lam.; Wu, Y-Jye.; Pang, S-Fun.; Cho, C-Hin., 2005:
Anti-tumorigenic and Pro-apoptotic effects of CKBM on gastric cancer growth in nude mice

Tang, H.; Inoue, M.; Uzawa, Y.; Kawamura, Y., 2005:
Anti-tumorigenic components of a sea weed, Eeteromorpha clathrata

Takamiya, K., 1960:
Anti-tumour activities of copper chelates

Preethi, K.C.; Kuttan, G.; Kuttan, R., 2006:
Anti-tumour activity of Ruta graveolens extract

Clézardin, P., 2005:
Anti-tumour activity of zoledronic acid

Manesh, C.; Kuttan, G., 2003:
Anti-tumour and anti-oxidant activity of naturally occurring isothiocyanates

Yamanoto, T.; Yamaoka, S.; Umezawa, H.; Takeuchi, T.; Nitta, K., 1954:
Anti-tumour effects of sarkomycin

Gardam, M.A.; Keystone, E.C.; Menzies, R.; Manners, S.; Skamene, E.; Long, R.; Vinh, D.C., 2003:
Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management

Licata, G.; Pinto, A.; Tuttolomondo, A.; Banco, A.; Ciccia, F.; Ferrante, A.; Triolo, G., 2003:
Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome

Hueber, A.J.; Tunc, A.; Schett, G.; Manger, B., 2007:
Anti-tumour necrosis factor alpha therapy in patients with impaired renal function

Hyrich, K.L.; Silman, A.J.; Watson, K.D.; Symmons, D.P.M., 2004:
Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety

Symmons, D.P.M., 2005:
Anti-tumour necrosis factor alpha therapy: can we afford it?

Jois, R.N.; Gaffney, K.; Keat, A., 2007:
Anti-tumour necrosis factor therapy for ankylosing spondylitis--unresolved issues

Thukral, C.; Cheifetz, A.; Peppercorn, M.A., 2006:
Anti-tumour necrosis factor therapy for ulcerative colitis: evidence to date

Catherine, S.; Bowness, P., 2005:
Anti-tumour necrosis factor therapy in seronegative spondyloarthritis

Ornetti, P.; Chevillotte, Hélène.; Zerrak, A.; Maillefert, J.Francis., 2006:
Anti-tumour necrosis factor-alpha therapy for rheumatoid and other inflammatory arthropathies: update on safety in older patients

Kilic, S.Sebnem., 2005:
Anti-tumour necrosis factor-alpha treatment of juvenile idiopathic arthritis in a patient with common variable immunodeficiency

Das, R.Kumar.; Bhattacharya, S., 2005:
Anti-tumour promoting activity of diphenylmethyl selenocyanate against two-stage mouse skin carcinogenesis

De Gregorio, M., 1960:
Anti-tussive activity in man and pharmaco-therapeutic characteristics of oxolamine (Perebron)

Chen, S.; Min, L.; Li, Y.; Li, W.; Zhong, D.; Kong, W., 2004:
Anti-tussive activity of benproperine enantiomers on citric-acid-induced cough in conscious guinea-pigs

Kawahata, K., 2005:
Anti-type II collagen autoantibodies in rheumatoid arthritis

Yoshida, S.; Haque, A.; Mizobuchi, T.; Iwata, T.; Chiyo, M.; Webb, T.J.; Baldridge, L.A.; Heidler, K.M.; Cummings, O.W.; Fujisawa, T.; Blum, J.S.; Brand, D.D.; Wilkes, D.S., 2006:
Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants

Louzada, A., 1953:
Anti-typhoid agglutinins and chloromycetin

Mazzetti, G., 1954:
Anti-typhoid vaccination in a single injection

Suri, J.C., 1957:
Anti-typhoid vaccine. I. Choice of an active-protection test

Legrand, J.C.; Gonnard, P.; Grupper, C., 1961:
Anti-tyrosinase activity of the blood of patients with malignant melanoma. Study with the aid of Warburg's apparatus

Grupper, C., 1954:
Anti-tyrosinase activity of the serum: preliminary note on the possibility of serodiagnosis of malignant melanoma

Bafna, P.A.; Balaraman, R., 2003:
Anti-ulcer and antioxidant activity of DHC-1, a herbal formulation

Vargha, G.; Szabo, S., 1958:
Anti-ulcer factor U in therapy of peptic ulcer with vit-U-pept gastrointestinal tablets

Anandan, R.; Nair, P.G.Viswanathan.; Mathew, S., 2004:
Anti-ulcerogenic effect of chitin and chitosan on mucosal antioxidant defence system in HCl-ethanol-induced ulcer in rats

Cerati, M., 1953:
Anti-ulcerous action of enterogastrone recovered from gastric juice by means of catheterization

Sonnen, N.; Goldhamer, R.; Carson, S., 1962:
Anti-uterotropic effect of N,N'-diphenyl-p-phenylenediamine on immature mice

Blume, S., 2005:
Anti-vaccination movements and their interpretations

Schlenker, T., 2004:
Anti-vaccinationists and their impact on vaccination coverage in Wisconsin

Peirce, E.R.; Melville, F.S.; Downie, A.W.; Duckworth, M.J., 1958:
Anti-vaccinial gamma-globulin in smallpox prophylaxis

Dachs, G.U.; Steele, A.J.; Coralli, C.; Kanthou, C.; Brooks, A.C.; Gunningham, S.P.; Currie, M.J.; Watson, A.I.; Robinson, B.A.; Tozer, G.M., 2006:
Anti-vascular agent Combretastatin A-4-P modulates hypoxia inducible factor-1 and gene expression

Takano, S.; Tsuboi, K.; Matsumura, A.; Nose, T., 2003:
Anti-vascular endothelial growth factor antibody and nimustine as combined therapy: effects on tumour growth and angiogenesis in human glioblastoma xenografts

Sandler, A.B.; Johnson, D.H.; Herbst, R.S., 2004:
Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer

Wu, Y.; Zhong, Z.; Huber, J.; Bassi, R.; Finnerty, B.; Corcoran, E.; Li, H.; Navarro, E.; Balderes, P.; Jimenez, X.; Koo, H.; Mangalampalli, V.R.M.; Ludwig, D.L.; Tonra, J.R.; Hicklin, D.J., 2006:
Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer

Watanabe, H.; Mamelak, A.J.; Wang, B.; Howell, B.G.; Freed, I.; Esche, C.; Nakayama, M.; Nagasaki, G.; Hicklin, D.J.; Kerbel, R.S.; Sauder, D.N., 2004:
Anti-vascular endothelial growth factor receptor-2 (Flk-1/KDR) antibody suppresses contact hypersensitivity

Watanabe, H.; Mamelak, A.J.; Weiss, E.; Wang, B.; Freed, I.; Brice, A.K.; Wachtman, L.; Gabrielson, K.L.; Yokota, N.; Hicklin, D.J.; Kerbel, R.S.; Haas, M.; Sauder, D.N., 2005:
Anti-vascular endothelial growth factor receptor-2 antibody accelerates renal disease in the NZB/W F1 murine systemic lupus erythematosus model

Csaky, K., 2003:
Anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration: promises and pitfalls

Jurado Garcia, E., 1952:
Anti-venereal campaign in the Mexican Army

Ducrey, C., 1960:
Anti-venereal prophylaxis, total abolitionism and international associations

Peruccio, L.; Vercellino, L., 1952:
Anti-venereal service in preventive and penal institutions

Biswas, R.; Irodi, A.; Paul, A.; Ghimere, G.; Joshi, K.R.; Alurkar, V.M.; Shetty, K.J., 2004:
Anti-venom-induced myelopathy in a semipoisonous snakebite

Seeman, E.; Crans, G.G.; Diez-Perez, A.; Pinette, K.V.; Delmas, P.D., 2005:
Anti-vertebral fracture efficacy of raloxifene: a meta-analysis

Sobel, R.A., 2007:
Anti-viral T-cell immunity+anti-CNS autoantibody=a model for human acute disseminated encephalomyelitis or multiple sclerosis relapse?

Perkins, E.S.; Wood, R.M.; Sears, M.L.; Prusoff, W.H.; Welch, A.D., 1962:
Anti-viral activities of several iodinated pyrimidine deoxyribonucleosides

Paisey, S.J.; Sadler, P.J., 2004:
Anti-viral cyclam macrocycles : rapid zinc uptake at physiological pH

Coulombeau, B.; Nusa Naiman, A.; Ceruse, P.; Froehlich, P., 2003 :
Anti-viral injectable treatment (cidofovir) in laryngeal papillomatosis

Idilman, R., 2006:
Anti-viral prophylaxis in inactive hepatitis B virus carriers with hemato-oncological malignancies who receive chemotherapy

Kühl, U.; Pauschinger, M.; Poller, W.; Schultheiss, H.P., 2005:
Anti-viral treatment in patients with virus-induced cardiomyopathy

Arbatsky, Y.G., 1961:
Anti-virus and anti-tumor agents

Anonymous, 2005:
Anti-virus breakthrough on the horizon. MAVs proteins may play major new role in the human immune system

Chen, G.; Chen, J.; Liu, D.; Zhang, X.; Zhu, C.; Li, Y.; Wang, L.; Yang, Y.; Cai, G.; Han, F., 2004:
Anti-virus effect of hepatocyte stimulating substance (HSS) on duck hepatitis B virus in vivo

Hove, E.L., 1955:
Anti-vitamin E stress factors as related to lipid peroxides

Bertoye, A.; Garin, J.P.; Germain, D.; Narjoux, J.; Sedallian, P., 1956:
Anti-whooping cough globulins in the curative treatment and prevention of whooping cough in young children

Soprano, D.; Romano, E., 1958:
Anti-whooping cough vaccination

Martin Du Pan, R.; Zourbas, J., 1957:
Anti-whooping cough vaccination in infants. I. Acquired immunity in newborn and infants. II. Comparative study of three mixed absorbed vaccines

Zourbas, J., 1951:
Anti-whooping cough vaccination; practical suggestions

Ikic, D.; Benkovic, J., 1955:
Anti-whooping cough vaccine prepared by various methods; experiments on mice

Hostettler, M.; Flack, H.D., 2003:
Anti-wurtzite reoriented

Delorenzi, E.; Florio, G., 1956:
Anti-x-ray gloves with insufficient protection

Grangaud, R.; Massonet, R., 1954:
Anti-xerophthalmic activity of astaxanthin esters

Sordet, C.; Gottenberg, J.E.; Goetz, J.; Bengoufa, D.; Humbel, R-L.; Mariette, X.; Sibilia, J., 2005:
Anti-{alpha}-fodrin autoantibodies are not useful diagnostic markers of primary Sjögren's syndrome

Braddock, M., 2005:
AntiArthritis Therapies 2005

Jaeger, G.; Linkesch, W.; Temmel, W.; Neumeister, P., 2005:
AntiCD20 monoclonal antibody-based radioimmunotherapy of relapsed chemoresistant aggressive post-transplantation B-lymphoproliferative disorder in heart-transplant recipient

Di Pietro, C.; Di Pietro, V.; Emmanuele, G.; Ferro, A.; Maugeri, T.; Modica, E.; Pigola, G.; Pulvirenti, A.; Purrello, M.; Ragusa, M.; Scalia, M.; Shasha, D.; Travali, S.; Zimmitti, V., 2006:
AntiClustal: Multiple Sequence Alignment by antipole clustering and linear approximate 1-median computation

Toseland, C.P.; Clayton, D.J.; McSparron, H.; Hemsley, S.L.; Blythe, M.J.; Paine, K.; Doytchinova, I.A.; Guan, P.; Hattotuwagama, C.K.; Flower, D.R., 2005:
AntiJen: a quantitative immunology database integrating functional, thermodynamic, kinetic, biophysical, and cellular data

La Marca, A.; Volpe, A., 2006:
AntiMüllerian serum levels during pregnancy

Sekut, L.; Connolly, K., 2005:
AntiTNF-alpha agents in the treatment of inflammation

De Bandt, M., 2006:
AntiTNFalpha-induced systemic vasculitis and autoimmune disorders

Oaks, L., 2003:
Antiabortion positions and young women's life plans in contemporary Ireland

Imai, S.; Shigei, T.; Hashimoto, K., 1961:
Antiaccelerator action of methoxamine

Margolin, S.; Lu, G.; Yelnosky, J.; Makovsky, A., 1954:
Antiaccelerator and anti-arrhythmic cardiac action of synthetic steroid alkamines

Herink, J.; Krejcová, G.; Bajgar, Jí., 2003:
Antiacetylcholinesterase activity of cyclosporine--a comparison of single and repeated administration and effect of 7-methoxytacrine

Angela, G.C.; Leone, G.; Novara, O., 1969:
Antiadenovirus antibodies in mother-foetus serum pairs

Lishko, V.K.; Burke, T.; Ugarova, T., 2006:
Antiadhesive effect of fibrinogen: a safeguard for thrombus stability

Kim, J.Hong.; Lee, J-Hwan.; Yoon, J-heon.; Chang, J.Hyun.; Bae, J.Ho.; Kim, K-Su., 2007:
Antiadhesive effect of the mixed solution of sodium hyaluronate and sodium carboxymethylcellulose after endoscopic sinus surgery

Makhrova, T.V.; Maianskiĭ, A.N.; Zaslavskaia, M.I., 2005:
Antiadhesive effect of the secretion of the oral cavity in the system "Candida albicans--buccal epitheliocytes"

Jackson, S.R.; Zhu, C-Hong.; Paulson, V.; Watkins, L.; Dikmen, Z.Gunnur.; Gryaznov, S.M.; Wright, W.E.; Shay, J.W., 2007:
Antiadhesive effects of GRN163L--an oligonucleotide N3'->P5' thio-phosphoramidate targeting telomerase

Rubina, K.A.; Tkachuk, V.A., 2004:
Antiadhesive molecule T-cadherin is an atypical low-density lipoprotein receptor in vascular cells

Zamboni, P.; Vitali, T., 1952:
Antiadrenalinics by concurrence of structure

Eichenberger, A.; Pontiggia, L.; Beer, J.H., 2003:
Antiaggregation: aspirin

Cattaneo, M.; Lecchi, A.; Ohno, M.; Joshi, B.V.; Besada, P.; Tchilibon, S.; Lombardi, R.; Bischofberger, N.; Harden, T.Kendall.; Jacobson, K.A., 2004:
Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptor

Bozikas, V.P.; Deseri, C.; Pitsavas, S.; Karavatos, A., 2003:
Antiaggressive action of combined risperidone and quetiapine in a patient with schizophrenia

Kreyden, O.P., 2006:
Antiaging - a scientific topic or just a social trend?

Calabrese, V.; Maines, M.D., 2006:
Antiaging medicine: antioxidants and aging

Banks, W.A.; Farr, S.A., 2004:
Antiaging methods and medicines for the memory

Vedamurthy, M., 2006:
Antiaging therapies

Ukraintseva, S.V.; Arbeev, K.G.; Michalsky, A.I.; Yashin, A.I., 2004:
Antiaging treatments have been legally prescribed for approximately thirty years

Sicard De Plauzoles, 1954:
Antialcoholic campaign; the physician's role in an antialcoholic campaign

Coeurdacier, 1957:
Antialcoholic consultations in Vosges in 1955

Domaradskii, I.V.; Klimova, I.M., 1964:
Antialdolase Activity of the Antiplague Serum and Difference in Aldolase Isolated from P. Pestis and its Toxin

Delagarza, S.A.; Canseco, C., 1964:
Antiallergic Action of Imipramine on the Uterus of Virgin Guinea Pigs Sensitized to a Protein Using the Shultz-Dale Technic

Mugler, A., 1953:
Antiallergic action of colchicum derivatives (colchicine, colchicoside)

Bocci, G., 1953:
Antiallergic action of cortisone in the eye. I. Protective effects in anaphylactic shock in the guinea pig

Dogliotti, G.C.; Lenti, G., 1951:
Antiallergic action of penicillin and other antibacterial drugs

Anonymous, 1951:
Antiallergic action of the sodium salt of p-aminosalicylic acid

Weicksel, 1950:
Antiallergic action of vigantol

Salomon, H., 1954:
Antiallergic activity of insulin

Anonymous, 2004:
Antiallergic agents from the chickweed

Milin, R.; Stern, P., 1956:
Antiallergic and antiphlogistic effect of azulenes

Boymond, P., 1953:
Antiallergic drugs and pharmacist

St Loup Bustillos, E., 1951:
Antiallergic drugs in the treatment of pregnancy vomiting

S.Loup Bustillos, E., 1951:
Antiallergic drugs in the treatment of vomiting in pregnancy

Kaiser, W.; Krosch, H., 1958:
Antiallergic effect of N-dimethylaminoisopropyl-thiophenylpyridylamine hydrochloride (Andantol, WZ)

Polak, F., 1955:
Antiallergic effect of Rauwolfia alkaloids reserpine

Bein, H.J.; Jaques, R.; Meier, R., 1956:
Antiallergic effect of bacterial polysaccharides

Castex, M.R., 1955:
Antiallergic effects of reserpine

Pani, A., 1952:
Antiallergic properties of para-aminobenzoic acid

Axenfeld, J.; Capurro, E.T., 1950:
Antiallergic properties of paraaminosalicylic acid

Girard, J.P., 1962:
Antiallergic properties of the cyproheptadine-dexamethasone combination. Antiserotonin activity of cyprohepatadine

Reuse, J.J., 1951:
Antiallergic therapy by synthetic antihistamines; correlation of pharmacological and therapeutic properties

Manfredi, P., 1951:
Antiallergic therapy in pregnancy hyperemesis

Loizzi, A., 1952:
Antiallergic therapy of grave burn shock

Schwarzmann, A., 1951:
Antiallergic therapy with synthetic haptens (poly-allerg and asthmallerg). III. Treatment of bronchial asthma with asthmallerg

Klovekorn, G.H., 1953:
Antiallergic treatment, antihistamine therapy, in dermatology

Nasio, J., 1960:
Antiallergic, antiphlogistic treatment and physiotherapy in gastroduodenal ulcer

Burckhalter, J.H.; Leib, R.I.; Chough, Y.S.; Tietz, R.F., 1963:
Antiamebic Agents. Vi. Analogs of Bialamicol and Related Quinolinols

Nobles, W.L.; Stephens, V.C.; Wei, L.; Burckhalter, J.H., 1958:
Antiamebic agents. IV. Quinolines and acridines with amino-hydroxy-alkylanilino side chains

Seneca, H., 1956:
Antiamebic and antibacterial synergism of tetracycline-nystatin-novobiocin combination

Goncalves, R.R., 1962:
Antiamebic chemotherapy

Galindo, L.Fonte.; Ferrer, M.de.los.Angeles.Fernández.; Valdés, L.Sánchez.; Iglesias, H.Marín.; Goodridge, Ión.Montano.; Mesa, J.Luis.Maestre., 2005:
Antiamebic effect of metronidazole proved in a study conducted in Cienfuegos province

Basel, A.A.; Petrov, V.E.; Trofimov, S.S.; Voronina, T.A.; Aliautdin, R.N., 2006:
Antiamnesic activity of nerve growth factor adsorbed on poly(butyl) cyanoacrylate nanoparticles coated with polysorbate-80

Losev, N.A.; Fedotova, Y.O.; Sapronov, N.S., 2006:
Antiamnesic effect of combined treatment with galantamine and estradiol in middle-aged ovariectomized female rats

Padilla, N.; Diaz, R.; Alarcon, A.; Barreda, R., 2003:
Antiamoebic chemoprophylaxis using quinfamide in children: a comparative study

Nguyen-Huu, B.K.; Urban, P.P.; Schreckenberger, M.; Dieterich, M.; Werhahn, K.J., 2006:
Antiamphiphysin-positive stiff-person syndrome associated with small cell lung cancer

Nikolov, R.; Richardson, J.S., 2004:
Antiamyloid strategies for the treatment of Alzheimer's disease

Puca, A., 1958:
Antianaphylactic & anti-allergic properties of post-shock cerebrospinal fluid

Girard, J.P., 1963:
Antianaphylactic Properties of 9-(N-Methyl-4'-Piperidylidene) Thioxanthene (Bp 400) and Lysozyme, Compared to those of Prednisone

Ostroumov, A.I., 1965:
Antianaphylactic Properties of Lagochylus and Dimedrol in the Sensitization of Animals with Ambrosia Pollen

Lauria, D.; Iuliani, G., 1952:
Antianaphylactic action of isonicotinic acid hydrazide

Tesi, A.; Giusti, G., 1951:
Antianaphylactic and antiallergic action of penicillin

Ganley, O.H.; Robinson, H.J., 1959:
Antianaphylactic and antiserotonin activity of a compound obtained from eggyolk, peanut oil and soybean lecithin

Couke, P.A.; Jichliski, P.; Matzinger, O.; Ozsahin, M.; Bulling, S.M.; Zouhair, A., 2004:
Antiandrogen gynecomastia: an inescapable harm? Radiotherapy: a simple and efficient solution!

Maeda, O.; Usami, M., 2003:
Antiandrogen in prostate cancer

Balañá, M.E.; Alvarez Roger, C.; Dugour, A.V.; Kerner, N.A., 2004:
Antiandrogen oligonucleotides: active principles in hair- and skin-derived culture cells

Harper, J.C., 2006:
Antiandrogen therapy for skin and hair disease

Altwein, J.; Hoesl, C.E., 2006:
Antiandrogen therapy of prostate carcinoma

Small, E.J.; Halabi, S.; Dawson, N.A.; Stadler, W.M.; Rini, B.I.; Picus, J.; Gable, P.; Torti, F.M.; Kaplan, E.; Vogelzang, N.J., 2004:
Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583)

Lin, A.D.Y.; Chen, K-Kuo.; Lin, A.T.L.; Chang, Y-Hwa.; Wu, H.H.H.; Kuo, J-Yih.; Huang, W.J.S.; Hsu, Y-Shen.; Chung, H-Jen.; Chang, L.S., 2004:
Antiandrogen-associated hepatotoxicity in the management of advanced prostate cancer

Khouri, N.Azar.; El-Akawi, Z., 2005:
Antiandrogenic activity of Ruta graveolens L in male Albino rats with emphasis on sexual and aggressive behavior

Lee, H.Ju.; Chattopadhyay, S.; Gong, E-Yeung.; Ahn, R.Sup.; Lee, K., 2003:
Antiandrogenic effects of bisphenol A and nonylphenol on the function of androgen receptor

Schindler, A.E., 2004:
Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception

Chen, K-Chou.; Peng, C-Chi.; Hsieh, H-Mei.; Peng, C-Huei.; Hsieh, C-Lan.; Huang, C-Ning.; Chyau, C-Cherng.; Wang, H-Er.; Peng, R.Y., 2005:
Antiandrogenic therapy can cause coronary arterial disease

Falzoi, M.; Gelati, M., 1952:
Antianemic action of cobalt; changes in sideremia induced by the treatment of neoplastic anemia with COCl2

Frada, G.; Cappello, F., 1950:
Antianemic action of duodenal mucosa

Gajdos, A., 1950:
Antianemic action of methionine

Dumazert, C.; Vermeulen, M., 1950:
Antianemic activity of the liver of rats subjected to protein inanition

Falzoi, M.; Gelati, M., 1952:
Antianemic effect of cobalt. I. Cobaltous chloride therapy in neoplastic anemia

Tastaldi, H., 1949:
Antianemic factor of the liver and vitamin B12

Dasher, W.A.; Bogen, E., 1952:
Antianemic factors in the treatment of iron deficiency anemias

Raos, V.; Bergovec, M., 2004:
Antianginal and antiadrenergic therapy in acute coronary syndrome

Shlyakhto, E.V.; Almazov, V.V.A.; Nifontov, E.M.; Vakhrameyeva, I.V.; Rudomanov, O.G.; Zakharov, D.V.; Kazarin, V.V.; Vakhrameyeva, N.V., 2004:
Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris

Ruzyllo, W.; Tendera, M.; Ford, I.; Fox, K.M., 2007:
Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial

Sabharwal, N.Kumar.; Lahiri, A., 2003:
Antianginal medications and diagnostic accuracy of myocardial perfusion imaging

Steel, H.H., 1964:
Antianginal, Vasopressor, Cardiotonic Drugs--Current Status and Rational

Mousa, S.A.; Mohamed, S.; Wexler, E.J.; Kerr, J.S., 2005:
Antiangiogenesis and anticancer efficacy of TA138, a novel alphavbeta3 antagonist

Classen, J.; Budach, W., 2003:
Antiangiogenesis and radiotherapy: what is the role of combined modality treatment?

Ribatti, D.; Vacca, A.; Merchionne, F.; Presta, M., 2005:
Antiangiogenesis by chemotherapeutic agents

Mariani, S.M., 2005:
Antiangiogenesis cocktails - stirred or shaken?

Zhong, H.; Bowen, J.Phillip., 2006:
Antiangiogenesis drug design: multiple pathways targeting tumor vasculature

McCarthy, M., 2003:
Antiangiogenesis drug promising for metastatic colorectal cancer

Fu, Q-Hong.; Yu, H.; Wang, Q-Qing.; Wu, Q-Liang., 2003:
Antiangiogenesis effect of linomide in treatment of transplanted human oral carcinoma in nude mice and its relations to regulation on cytokine secretion of macrophage

Roccaro, A.M.; Russo, F.; Cirulli, T.; Di Pietro, G.; Vacca, A.; Dammacco, F., 2005:
Antiangiogenesis for rheumatoid arthritis

Folkman, J., 2005:
Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action

Kirchmair, R.; Walter, D.H.; Ii, M.; Rittig, K.; Tietz, A.B.; Murayama, T.; Emanueli, C.; Silver, M.; Wecker, A.; Amant, C.; Schratzberger, P.; Yoon, Y-Sup.; Weber, A.; Panagiotou, E.; Rosen, K.M.; Bahlmann, F.H.; Adelman, L.S.; Weinberg, D.H.; Ropper, A.H.; Isner, J.M.; Losordo, D.W., 2005:
Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth

Sjølie, A.Katrin.; Mortensen, K.Kamp.; Hansen, M.H., 2005:
Antiangiogenesis therapy of age-related macular degeneration

Morioka, H.; Weissbach, L.; Vogel, T.; Nielsen, G.Petur.; Faircloth, G.T.; Shao, L.; Hornicek, F.J., 2003:
Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis

Harris, R.E., 2006:
Antiangiogenesis: New Frontiers in Therapeutic Development--IBC's Fourth Annual International Symposium

Longoria, R.L.; Cox, M.C.; Figg, W.D., 2006:
Antiangiogenesis: a possible treatment option for prostate cancer?

Camp-Sorrell, D., 2003:
Antiangiogenesis: the fifth cancer treatment modality?

Pietras, R.J.; Weinberg, O.K., 2005:
Antiangiogenic Steroids in Human Cancer Therapy

Roy, A.M.; Tiwari, K.N.; Parker, W.B.; Secrist, J.A.; Li, R.; Qu, Z., 2006:
Antiangiogenic activity of 4'-thio-beta-D-arabinofuranosylcytosine

Folkman, J., 2003:
Antiangiogenic activity of a matrix protein

Chalmers, C.R.; Wilson, D.J.; Ward, J.; Robinson, P.J.; Toogood, G.J.; Hull, M.A., 2006:
Antiangiogenic activity of the selective cyclooxygenase 2 inhibitor rofecoxib in human colorectal cancer liver metastases

Nakamura, T.; Ozawa, S.; Kitagawa, Y.; Ueda, M.; Kubota, T.; Kitajima, M., 2005:
Antiangiogenic agent SU6668 suppresses the tumor growth of xenografted A-431 cells

Lenz, H-Josef., 2005:
Antiangiogenic agents in cancer therapy

Furness, M.S.; Robinson, T.P.; Ehlers, T.; Hubbard, R.B.; Arbiser, J.L.; Goldsmith, D.J.; Bowen, J.P., 2005:
Antiangiogenic agents: studies on fumagillin and curcumin analogs

Strauss, L.; Volland, D.; Guerrero, A.; Reichert, T., 2005:
Antiangiogenic and anti-immunosuppressive therapeutic strategies in human head and neck squamous cell carcinoma (HNSCC)

Gangjee, A.; Yang, J.; Ihnat, M.A.; Kamat, S., 2003:
Antiangiogenic and antitumor agents. Design, synthesis, and evaluation of novel 2-amino-4-(3-bromoanilino)-6-benzylsubstituted pyrrolo[2,3-d]pyrimidines as inhibitors of receptor tyrosine kinases

Wedam, S.Bonthala.; Low, J.A.; Yang, S.X.; Chow, C.K.; Choyke, P.; Danforth, D.; Hewitt, S.M.; Berman, A.; Steinberg, S.M.; Liewehr, D.J.; Plehn, J.; Doshi, A.; Thomasson, D.; McCarthy, N.; Koeppen, H.; Sherman, M.; Zujewski, J.; Camphausen, K.; Chen, H.; Swain, S.M., 2006:
Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer

Cantaluppi, V.; Biancone, L.; Romanazzi, G.Mauriello.; Figliolini, F.; Beltramo, S.; Ninniri, M.S.; Galimi, F.; Romagnoli, R.; Franchello, A.; Salizzoni, M.; Perin, P.Cavallo.; Ricordi, C.; Segoloni, G.P.; Camussi, G., 2006:
Antiangiogenic and immunomodulatory effects of rapamycin on islet endothelium: relevance for islet transplantation

Deepak, A.V.; Salimath, B.P., 2005:
Antiangiogenic and proapoptotic activity of a novel glycoprotein from U. indica is mediated by NF-kappaB and Caspase activated DNase in ascites tumor model

Mukherjee, P.; Abate, L.E.; Seyfried, T.N., 2004:
Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors

Belleri, M.; Ribatti, D.; Nicoli, S.; Cotelli, F.; Forti, L.; Vannini, V.; Stivala, L.Anna.; Presta, M., 2005:
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene

Zhang, W.; Chuang, Y-Jen.; Swanson, R.; Li, J.; Seo, K.; Leung, L.; Lau, L.F.; Olson, S.T., 2003:
Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells

Gille, J., 2006:
Antiangiogenic cancer therapies get their act together: current developments and future prospects of growth factor- and growth factor receptor-targeted approaches

Pourroy, B.; Honoré, Séphane.; Pasquier, E.; Bourgarel-Rey, Véronique.; Kruczynski, A.; Briand, C.; Braguer, D., 2006:
Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells

Cascone, T.; Troiani, T.; Morelli, M.Pia.; Gridelli, C.; Ciardiello, F., 2006:
Antiangiogenic drugs in non-small cell lung cancer treatment

Prabhakar, B.T.; Khanum, S.Ara.; Shashikanth, S.; Salimath, B.P., 2006:
Antiangiogenic effect of 2-benzoyl-phenoxy acetamide in EAT cell is mediated by HIF-1alpha and down regulation of VEGF of in-vivo

Ahmad, S.; Ahmed, A., 2005:
Antiangiogenic effect of soluble vascular endothelial growth factor receptor-1 in placental angiogenesis

Kumar, M.; Liu, Z-Ren.; Thapa, L.; Chang, Q.; Wang, D-Yu.; Qin, R-Yi., 2004:
Antiangiogenic effect of somatostatin receptor subtype 2 on pancreatic cancer cell line: Inhibition of vascular endothelial growth factor and matrix metalloproteinase-2 expression in vitro

Cañete, J.D.; Pablos, Jé.L.; Sanmartí, R.; Mallofré, C.; Marsal, S.; Maymó, J.; Gratacós, J.; Mezquita, J.; Mezquita, C.; Cid, M.C., 2004:
Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis

Badruddoja, M.A.; Krouwer, H.G.J.; Rand, S.D.; Rebro, K.J.; Pathak, A.P.; Schmainda, K.M., 2003:
Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps

Davidoff, A.M.; Nathwani, A.C., 2004:
Antiangiogenic gene therapy for cancer treatment

Tandle, A.; Blazer, D.G.; Libutti, S.K., 2004:
Antiangiogenic gene therapy of cancer: recent developments

Drevs, J.; Löser, R.; Rattel, B.; Esser, N., 2004:
Antiangiogenic potency of FK866/K22.175, a new inhibitor of intracellular NAD biosynthesis, in murine renal cell carcinoma

Miyazawa, T.; Tsuzuki, T.; Nakagawa, K.; Igarashi, M., 2005:
Antiangiogenic potency of vitamin E

Del Bufalo, D.; Ciuffreda, L.; Trisciuoglio, D.; Desideri, M.; Cognetti, F.; Zupi, G.; Milella, M., 2006:
Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus

Kaur, G.; Belotti, D.; Burger, A.M.; Fisher-Nielson, K.; Borsotti, P.; Riccardi, E.; Thillainathan, J.; Hollingshead, M.; Sausville, E.A.; Giavazzi, R., 2004:
Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator

Mukherjee, P.; Bhattacharya, R.; Wang, P.; Wang, L.; Basu, S.; Nagy, J.A.; Atala, A.; Mukhopadhyay, D.; Soker, S., 2005:
Antiangiogenic properties of gold nanoparticles

Bierhaus, A.; Nawroth, P.P., 2004 :
Antiangiogenic properties of low molecular weight heparin - does tissue factor provide the answer?

Zacharoulis, D.; Hatzitheofilou, C.; Athanasiou, E.; Zacharoulis, S., 2005:
Antiangiogenic strategies in hepatocellular carcinoma: current status

Ribatti, D.; Ponzoni, M., 2005:
Antiangiogenic strategies in neuroblastoma

Dowell, J.E.; Kindler, H.Lee., 2005:
Antiangiogenic therapies for mesothelioma

Hampton, T., 2005:
Antiangiogenic therapy a two-trick pony?

Blagosklonny, M.V., 2004:
Antiangiogenic therapy and tumor progression

Ellis, L.M., 2003:
Antiangiogenic therapy at a crossroads: clinical trial results and future directions

Schmidt, N.Ole.; Ziu, M.; Carrabba, G.; Giussani, C.; Bello, L.; Sun, Y.; Schmidt, K.; Albert, M.; Black, P.Mcl.; Carroll, R.S., 2004:
Antiangiogenic therapy by local intracerebral microinfusion improves treatment efficiency and survival in an orthotopic human glioblastoma model

Islam, S.; Newman, E.A.; Strouse, P.J.; Geiger, J.D., 2005:
Antiangiogenic therapy for a large splenic hemangioma

Jain, R.K., 2005:
Antiangiogenic therapy for cancer: current and emerging concepts

Jia, L.; Zhang, M-Hua.; Yuan, S-Zhen.; Huang, W-Ge., 2005:
Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice

Purow, B.; Fine, H.A., 2004:
Antiangiogenic therapy for primary and metastatic brain tumors

Davidoff, A.M.; Kandel, J.J., 2004:
Antiangiogenic therapy for the treatment of pediatric solid malignancies

Madhusudan, S.; Deplanque, Gël.; Braybrooke, J.P.; Cattell, E.; Taylor, M.; Price, P.; Tsaloumas, M.D.; Moore, N.; Huson, S.M.; Adams, C.; Frith, P.; Scigalla, P.; Harris, A.L., 2004:
Antiangiogenic therapy for von Hippel-Lindau disease

Hatfield, K.J.; Olsnes, A.M.; Gjertsen, B.Tore.; Bruserud, Øystein., 2005:
Antiangiogenic therapy in acute myelogenous leukemia: targeting of vascular endothelial growth factor and interleukin 8 as possible antileukemic strategies

Zent, R.; Pozzi, A., 2006:
Antiangiogenic therapy in diabetic nephropathy

Heidemann, J.; Binion, D.G.; Domschke, W.; Kucharzik, T., 2006:
Antiangiogenic therapy in human gastrointestinal malignancies

Vogt, T.; Coras, B.; Hafner, C.; Landthaler, M.; Reichle, A., 2006:
Antiangiogenic therapy in metastatic prostate carcinoma complicated by cutaneous lupus erythematodes

Lin, R.C.; Rosenfeld, P.J., 2007:
Antiangiogenic therapy in neovascular age-related macular degeneration

Leenders, W.P.J.; Küsters, B.; Verrijp, K.; Maass, C.; Wesseling, P.; Heerschap, A.; Ruiter, D.; Ryan, A.; de Waal, R., 2004:
Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option

Riedel, F.; Götte, K.; Hörmann, K.; Grandis, J.Rubin., 2004:
Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy

Sproull, M.; Brechbiel, M.; Camphausen, K., 2003:
Antiangiogenic therapy through copper chelation

Reddy, U.; Kryzstolik, M., 2006:
Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration

Coras, B.; Hafner, C.; Reichle, A.; Hohenleutner, U.; Szeimies, R-Markus.; Landthaler, M.; Vogt, T., 2004:
Antiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcoma

Ellis, L.M., 2003:
Antiangiogenic therapy: more promise and, yet again, more questions

Tandle, A.; Libutti, S.K., 2005:
Antiangiogenic therapy: targeting vascular endothelial growth factor and its receptors

Mauriz, Jé.L.; Linares, P.; González, P.; Culebras, Jús.M., 2006:
Antiangiogenic treatment of cancer

Heidemann, J.; Ogawa, H.; Otterson, M.F.; Shidham, V.B.; Binion, D.G., 2004:
Antiangiogenic treatment of mesenteric desmoid tumors with toremifene and interferon alfa-2b: report of two cases

Zhang, X.; Galardi, E.; Duquette, M.; Delic, M.; Lawler, J.; Parangi, S., 2005:
Antiangiogenic treatment with the three thrombospondin-1 type 1 repeats recombinant protein in an orthotopic human pancreatic cancer model

Zhang, X.; Galardi, E.; Duquette, M.; Lawler, J.; Parangi, S., 2005:
Antiangiogenic treatment with three thrombospondin-1 type 1 repeats versus gemcitabine in an orthotopic human pancreatic cancer model

Aslan, H.; Pay, S.; Gok, F.; Baykal, Y.; Yilmaz, M.I.; Sengul, A.; Aydin, H.I., 2003:
Antiannexin V autoantibody in thrombophilic Behçet's disease

Toruner, M.; Fernandez-Zapico, M.; Sha, J.Jing.; Pham, L.; Urrutia, R.; Egan, L.J., 2006:
Antianoikis effect of nuclear factor-kappaB through up-regulated expression of osteoprotegerin, BCL-2, and IAP-1

Maloney, G., 2004:
Antianxiety medications: a review of mechanisms & presentations of drug-related emergencies

Ploszaj, T.; Motyl, T.; Orzechowski, A.; Zimowska, W.; Wareski, P.; Skierski, J.; Zwierzchowski, L., 2003:
Antiapoptotic action of prolactin is associated with up-regulation of Bcl-2 and down-regulation of Bax in HC11 mouse mammary epithelial cells

Yenari, M.A.; Liu, J.; Zheng, Z.; Vexler, Z.S.; Lee, J.Eun.; Giffard, R.G., 2005:
Antiapoptotic and anti-inflammatory mechanisms of heat-shock protein protection

Gwag, B.J.; Kim, S.H., 2003:
Antiapoptotic and pronecrotic actions of neurotrophins

Liu, W.M.; Baird, R.; Sarker, D.; Powles, T., 2005:
Antiapoptotic effect of growth factors in leukemia

Monastyrskaya, E.A.; Duchen, M.R.; Andreeva, L.V.; Viegant, F.; Manukhina, E.B.; Malyshev, I.Yu., 2003:
Antiapoptotic effect of heat adaptation in cultured cells

Xiang, M.; Wang, J.; Kaplan, E.; Oettgen, P.; Lipsitz, L.; Morgan, J.P.; Min, J-Yong., 2007:
Antiapoptotic effect of implanted embryonic stem cell-derived early-differentiated cells in aging rats after myocardial infarction

Verdaguer, E.; Jordá, E.G.; Canudas, A.M.; Jiménez, Aés.; Pubill, D.; Escubedo, E.; Camarasa, J.; Pallàs, Mè.; Camins, A., 2003:
Antiapoptotic effects of roscovitine in cerebellar granule cells deprived of serum and potassium: a cell cycle-related mechanism

Cohen-Saidon, C.; Carmi, I.; Keren, A.; Razin, E., 2005:
Antiapoptotic function of Bcl-2 in mast cells is dependent on its association with heat shock protein 90beta

Mayama, K.; Tsuzuki, S.; Seto, M., 2006:
Antiapoptotic functions of the retrovirally transferred API2-MALT1 gene

Gu, X.; Feng, Y.; Shi, C.; Li, M.; Fu, Z.; Zhang, X., 2006:
Antiapoptotic mechanism of insulin in reoxygenation-induced injury in cultured cardiomyocytes of neonatal rats

Neliudova, A.M.; Zubova, S.G.; Aksenov, N.D.; Pospelov, V.A.; Pospelova, T.V., 2006:
Antiapoptotic oncogene bcl-2 induces a program of senescence in E1A + c-Ha-ras-transformants treated with adriamycin

Beaumont, C., 2005:
Antiapoptotic role of ferritin heavy chain

Tehranchi, R.; Fadeel, B.; Schmidt-Mende, J.; Forsblom, A-Mari.; Emanuelsson, E.; Jadersten, M.; Christensson, B.; Hast, R.; Howe, R.B.; Samuelsson, J.; Zhivotovsky, B.; Hellström-Lindberg, E., 2005:
Antiapoptotic role of growth factors in the myelodysplastic syndromes: concordance between in vitro and in vivo observations

Haura, E.B.; Cress, W.Douglas.; Chellappan, S.; Zheng, Z.; Bepler, G., 2004:
Antiapoptotic signaling pathways in non-small-cell lung cancer: biology and therapeutic strategies

King, R.Bruce.; Heine, T.; Corminboeuf, Cémence.; Schleyer, P.v.R., 2004:
Antiaromaticity in bare deltahedral silicon clusters satisfying Wade's and Hirsch's rules: an apparent correlation of antiaromaticity with high symmetry

Mills, N.S.; Levy, A.; Plummer, B.F., 2004:
Antiaromaticity in fluorenylidene dications. Experimental and theoretical evidence for the relationship between the HOMO/LUMO gap and antiaromaticity

Katz, R.L., 1964:
Antiarrhythmic Action of N, N-Bis (Phenylcarbamoylmethyl) Dimethyl Ammonium Chloride (Qx-572) in Cat and Dog

Gendenshtein, E.I.; Mikhailenko, L.A., 1964:
Antiarrhythmic Action of Serpentine in some Experimental Defects of the Auricular and Ventricular Rhythm

Garrett, J.; Moreira, G.; Osswald, M.W.; Guimaraes, S., 1964:
Antiarrhythmic Activity of N,n-Diisopropyl-N'-Isoamyl-N'-Diethylaminoethylurea Hydrochloride (P-286)

Katz, R.L., 1965:
Antiarrhythmic and Neuromuscular Effects of Qx-572 in man

Singh, S.N..; Patrick, J.; Patrick, J., 2004:
Antiarrhythmic Drugs

Lyon, A.F.; Degraff, A.C., 1965:
Antiarrhythmic Drugs. 3. Quinidine Toxicity

Lyon, A.F.; Degraff, A.C., 1965:
Antiarrhythmic Drugs. I. Mechanism of Quinidine Action

Lyon, A.F.; Degraff, A.C., 1965:
Antiarrhythmic Drugs. Ii. Clinical use of Quinidine

Ruthen, G.C., 1965 :
Antiarrhythmic Drugs. Iv. Diphenylhydantoin in Cardiac Arrhythmias

Kayden, H.J., 1965:
Antiarrhythmic Drugs. V. Pharmacology of Procaine Amide

Fedorov, V.V.; Rozenshtraukh, L.V.; Reznik, A.V.; Beloshapko, G.G.; Iushmanova, A.V.; Golitsyn, S.P.; Ruda, M.Ia.; Chazov, E.I., 2004:
Antiarrhythmic Efficacy of a New Class III Antiarrhythmic Drug RG-2.

Katz, R.L., 1963:
Antiarrhythmic action of synthetic oxytocin in anesthetized man

Bryzgalov, A.O.; Dolgikh, M.P.; Sorokina, I.V.; Tolstikova, T.G.; Sedova, V.F.; Shkurko, O.P., 2005:
Antiarrhythmic activity of 4,6-di(het)aryl-5-nitro-3,4-dihydropyrimidin-(1H)-2-ones and its effects on arterial pressure in rats

Sapronov, N.S.; Gavrovskaya, L.K.; Krylova, I.B.; Evdokimova, N.R., 2006:
Antiarrhythmic activity of taurhythman

Lasukova, T.V.; Krylatov, A.V.; Maslov, L.N.; Lishmanov, I.B.; Gross, G.J.; Podoksenov, I.K.; Podoksenov, A.Iu., 2004:
Antiarrhythmic and cardioprotective effect of stimulation of delta1-opiate receptors in myocardial ischemia and reperfusion

Redman, J.; Worthley, L.I., 2006:
Antiarrhythmic and haemodynamic effects of the commonly used intravenous electrolytes

Singh, B.N.; Wadhani, N., 2004:
Antiarrhythmic and proarrhythmic properties of QT-prolonging antianginal drugs

Turco, P.; De Simone, A.; La Rocca, V.; Iuliano, A.; Capuano, V.; Astarita, C.; Di Napoli, T.; Messina, V.; Baldi, S.; Stabile, G., 2007:
Antiarrhythmic drug therapy after radiofrequency catheter ablation in patients with atrial fibrillation

Reiffel, J.A.; Naccarelli, G.V., 2006:
Antiarrhythmic drug therapy for atrial fibrillation: are the guidelines guiding clinical practice?

Page, R.L., 2006:
Antiarrhythmic drugs for all patients with an ICD?

Nattel, S., 2004:
Antiarrhythmic drugs for atrial fibrillation: Do we need better use, better drugs or a randomized trial of ablation as primary therapy?

Choudhury, A.; Lip, G.Y.H., 2004:
Antiarrhythmic drugs in atrial fibrillation: an overview of new agents, their mechanisms of action and potential clinical utility

Bollmann, A.; Husser, D.; Cannom, D.S., 2005:
Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators

Alboni, P.; Gianfranchi, L.; Pacchioni, F.; Pedaci, M., 2005:
Antiarrhythmic drugs in patients with recurrent atrial fibrillation: where are we?

Nemec, J.; Shen, W-Kuang., 2003:
Antiarrhythmic drugs: new agents and evolving concepts

Mont, Lís., 2005:
Antiarrhythmic effect of cardiac resynchronization

Wu, Z-Kai.; Iivainen, T.; Pehkonen, E.; Laurikka, J.; Tarkka, M.R., 2003:
Antiarrhythmic effect of ischemic preconditioning in recent unstable angina patients undergoing coronary artery bypass grafting

Issa, Z.F.; Zipes, D.P., 2005:
Antiarrhythmic effects of targeted cardiac neuromodulation: is it time for clinical application?

Abraham, M.Roselle.; Henrikson, C.A.; Tung, L.; Chang, M.G.; Aon, M.; Xue, T.; Li, R.A.; O' Rourke, B.; Marbán, E., 2005:
Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation

Kozlovski, V.I.; Vdovichenko, V.P.; Chlopicki, S.; Malchik, S.S.; Praliyev, K.D.; Zcilkibayev, O.T., 2005:
Antiarrhythmic profile and endothelial action of novel decahydroquinoline derivatives

Filippova, O.V.; Kryzhanovskiĭ, S.A.; Peresada, V.P.; Likhosherstov, A.M.; Revenko, S.V.; Kaverina, N.V.; Reznikov, K.M., 2004:
Antiarrhythmic properties of 2-(2'-hydroxy-2')-substituted ethyl-1,2,3,4-octahydropyrrolo[1,2-a]pyrazines

Pines, I.; Salazar, E.; Lopez, T., 1958:
Antiarrhythmic properties of chlorothiazide

Matyushin, A.I.; Kaverina, N.V.; Shimanovskii, N.L.; Turilova, A.I., 2006:
Antiarrhythmic properties of estrogens

Deneke, T.; Khargi, K.; Grewe, P.H.; Kuschkowitz, F.; Laczkovics, A.; Lemke, B., 2004:
Antiarrhythmic surgery to cure atrial fibrillation--subgroups and postoperative management

Brown, W.S.; Kessell, G., 2006:
Antiarrhythmic therapy and ECG

Wase, A., 2006:
Antiarrhythmic therapy for prevention of implantable cardioverter defibrillator shocks

Ferrick, K.J., 2005:
Antiarrhythmic therapy in elderly persons: a device-based approach

Eckardt, L.; Haverkamp, W.; Breithardt, Günter., 2003:
Antiarrhythmic therapy in heart failure

Auer, J.; Berent, R.; Weber, T.; Ng, C.K.; Lassnig, E.; Lamm, G.; Eber, B., 2004:
Antiarrhythmic therapy on prevention of postoperative atrial fibrillation in patients after heart surgery

Arora, R.B.; Sharma, V.N.; Madan, B.R., 1955:
Antiarrhythmics. I. Chloroquine in auricular fibrillation

Arora, R.B.; Madan, B.R., 1956:
Antiarrhythmics. II. Amodiaquin (camoquin) in cardiac arrhythmias

Arora, R.B.; Madan, B.R., 1956:
Antiarrhythmics. III. Antiarrhythmic activity of Nardostachys jatamansi (an Indian indigenous drug)

Arora, R.B.; Sharma, V.N.; Madan, B.R., 1956:
Antiarrhythmics. V. Tridiurecaine, a new local anaesthetic in experimentally induced atrial flutter, atrial fibrillation and ventricular arrhythmia

Arora, R.B.; Madan, B.R., 1956:
Antiarrhythmics. VII. Quinidine-like activity of proguanil, supazine and daraprim

Arora, R.B.; Madan, B.R.; Pathak, R.K., 1956:
Antiarrhythmics. VIII. Chloroquine, amodiaquine, procaine amide and quinidine in experimental auricular arrhythmias simulating clinical disorders

Arora, R.B.; Sharma, P.L., 1958:
Antiarrhythmics. X. Antiarrhythmic and antiveratrinic action of some antihistaminic drugs

Gujral, M.L.; Sareen, K.N.; Tangri, K.K.; Roy, A.K.; Gupta, G.P.; Amma, M.K., 1959:
Antiarthritic activity of glycyrrhiza glabra Linn

Gujral, M.L.; Sareen, K.; Tangri, K.K.; Amma, M.K.; Roy, A.K., 1960:
Antiarthritic and anti-inflammatory activity of gum guggul (Balsamodendron mukul Hook)

Zorn, B.; Schmidt, F.H., 1954:
Antiarthritic derivatives of 1-phenyl-2,3-di-methyl-4-oxyacetyl-pyrazolone

Zorn, B.; Mankel, A., 1954:
Antiarthritic derivatives of 2-phenyl-4-(oxy-acetyl)-quinoline

Park, H.Ji.; Lee, S.Ho.; Son, D.Ju.; Oh, K.Wan.; Kim, K.Hyun.; Song, H.Sueb.; Kim, G.Joung.; Oh, G.Taeg.; Yoon, D.Young.; Hong, J.Tae., 2004:
Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit

Pedrazzoli, A.; Roggero, M., 1958:
Antiarthritics and antiallergics

Zorn, B., 1958:
Antiarthritis effect of the Harpagophytum root; preliminary report

Vegni, F.E.; Panceri, M.L.; Wilkinson, P., 2003:
Antiasthmatic drug consumption as an indicator of the prevalence of respiratory pathology in a pediatric population

Gazdik, F.; Jahnova, E.; Horvathova, M.; Pijak, M.R.; Gazdikova, K., 2004:
Antiasthmatic effects of nedocromil sodium

Koshiyama, H., 2005:
Antiatherogenic actions of etidronate on atherosclerosis

Ma, J-Yang.; Shi, Y-Kang.; Fang, D-Zhi., 2005:
Antiatherogenic effect of Huajiao volatile oil on experimental atherosclerosis in guinea pigs

Dedoussis, G.V.Z.; Kaliora, A.C.; Psarras, S.; Chiou, A.; Mylona, A.; Papadopoulos, N.G.; Andrikopoulos, N.K., 2004:
Antiatherogenic effect of Pistacia lentiscus via GSH restoration and downregulation of CD36 mRNA expression

Satoh, N.; Ogawa, Y.; Usui, T.; Tagami, T.; Kono, S.; Uesugi, H.; Sugiyama, H.; Sugawara, A.; Yamada, K.; Shimatsu, A.; Kuzuya, H.; Nakao, K., 2003:
Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect

Sethupathy, S.; Elanchezhiyan, C.; Vasudevan, K.; Rajagopal, G., 2003:
Antiatherogenic effect of taurine in high fat diet fed rats

Preobrazhenskiĭ, D.V.; Batyraliev, T.A.; Peresypko, M.K.; Pershukov, I.V.; Sidorenko, B.A., 2006:
Antiatherogenic effects of angiotensin converting enzyme inhibitors from positions (point of view) of evidence based medicine. Part I

Barter, P.J., 2005:
Antiatherogenic properties of fibrates

Escola-Gil, J.Carles.; Calpe-Berdiel, L.; Palomer, X.; Ribas, V.; Ordonez-Llanos, J.; Blanco-Vaca, F., 2005:
Antiatherogenic role of high-density lipoproteins: insights from genetically engineered-mice

Loeper, J.; Goy-Loeper, J.; Rozensztajn, L.; Fragny, M., 1979:
Antiatheromatous action of silicon

Tamches, A., 1953:
Antiatheromatous properties of heparin: objective clinical and biological

Wago, K., 1961:
Antiatherosclerotic and anticoagulant activity of cerebroside sulfate

Lonn, E., 2004:
Antiatherosclerotic effects of ACE inhibitors: where are we now?

Galesić, K., 2007:
Antiatherosclerotic effects of antihypertensive drugs

Uetake, Y.; Shimosawa, T., 2005:
Antiatherosclerotic hopes of calcium channel blockers

Piedrola Sala, F., 1959:
Antiatomic and thermonuclear aid group

Dufourmentel, C., 1965:
Antibacillus Treatment of Addison's Disease

Ozbey, Süheyla.; Akbaş, A.; Ayhan-Kilcigil, Gülgün.; Ertan, R., 2005:
Antibacterial 4-amino-N-(5-methylisoxazol-3-yl)-N-[(4-oxo-2-phenyl-4H-1-benzopyran-6-yl)methyl]benzenesulfonamide

Elmolla, A.H., 1965:
Antibacterial Action of Astiban

Kono, K.; Hashimoto, H.; Mitsuhashi, S., 1965:
Antibacterial Action of Lincomycin on Staphylococci

Wu, Y.L., 1962:
Antibacterial Action of Organic Compounds Against Pseudomonas Aeruginosa

Weinberg, E.D., 1963:
Antibacterial Action of Polyamines in Presence of Trace Metals: Enhancement by Cadmium

Adam, M.; Houba, V.; Stojan, B., 1964:
Antibacterial Action of Resochin and Experimental Inflammation

Przyjalkowski, Z., 1964:
Antibacterial Action of the Fluid from the Pseudo-Body Cavity of the Worm Ascaris Lumbricoides Suis on the Course of Experimental Erysipeloid in Mice

Dobrzanski, W.T.; Osowiecki, H.; Piatkowska, A., 1964:
Antibacterial Activity in Vitro of Nitrofurazone "polfa"

Castagnari, L., 1964:
Antibacterial Activity of Ampicillin on 45 Strains of Salmonella

Izawa, A.; Suzuki, M.; Rikimaru, M.; Ishida, N., 1964:
Antibacterial Activity of Certain Biguanide Derivatives

Castagnari, L., 1964:
Antibacterial Activity of Cloxacillin on 92 Staphylococcal Strains

Bonaduce, A.; Compagnucci, M., 1963:
Antibacterial Activity of Heat and of some Substances Studies with Warburg Method and with Electron Microscopy. Iii. Action of some Chemotherapeutic Agents on Brucella Abortus

Schneierson, S.S.; Shore, B., 1963:
Antibacterial Activity of Herpes Simplex Virus Grown in Tissue Culture

Solovev, V.N.; Konzhev, G.A.; Zueva, V.S.; Balyn, I.R.; Chumachenko, N.V.; Sokolova, E.M.; Kucherov, V.F.; Gusev, B.P., 1965:
Antibacterial Activity of Synthetic Capillene (Agropyrene) and Capilline Derivatives

Patania, S.; Decristofaro, R.; Virga, G., 1963:
Antibacterial Activity of Tetracyclines in Relation to its Fixation in Osseous Tissue

Banic, S.; Erjavec, F., 1964:
Antibacterial Activity of the Preparation "lekosept"

Boudart, G., 1989:
Antibacterial Activity of Sirodesmin PL Phytotoxin: Application to the Selection of Phytotoxin-Deficient Mutants

Hach, V.; Kvita, V., 1964:
Antibacterial Agents. Iv. Preparation of D-Chloramphenicol Cinnamate

Cavallini, G.; Massarani, E.; Nardi, D.; Mauri, L.; Tenconi, F.; Pacchiano, F.; Mantegazza, P., 1963:
Antibacterial Agents. some new Halomethyl Aryl Ketones

Bolek, S.; Smekal, M.; Vykydal, M.; Zizka, Z., 1965:
Antibacterial and Antimycotic Effects of Various Antimalarials

Pershin, G.N.; Belikov, G.P.; Danielian, H.M.; Katunina, V.I., 1964:
Antibacterial and Antiviral Action of some Lactones and Lactams

Burchall, J.J.; Ferone, R.; Hitchings, G.H., 1965:
Antibacterial Chemotherapy

Trendelenburg, F., 1964:
Antibacterial Chemotherapy of Tuberculosis

Lynch, A.Simon., 2005:
Antibacterial Drug Discovery and Development Summit - Tenth Annual SRI Summit

Smith, S.E., 1963:
Antibacterial Drugs

Sokolov, B.V.; Volf, L.A.; Markovich, A.V., 1964:
Antibacterial Effect of Polyvinyl Alcohol Fibers Containing Specific Chemical Groups

Houba, V.; Adam, M., 1964:
Antibacterial Effect of Resochin

Kolomoitsev, L.R.; Heonia, N.H.; Sheikman, A.K., 1963:
Antibacterial Effect of some N-Substituted Pyridine Derivatives. (Ii)

Kimelblat, M.A., 1964:
Antibacterial Effects of Tetracycline and Furacillin and of their Combinations on Shigella Sonnei and Flexneri in Vitro

Crisley, F.D., 1964:
Antibacterial Interaction Between Bromthymol Blue and Polymyxin B

Christov, G.; Todorov, D.; Ikonopissov, R., 1964:
Antibacterial Properties at the Level of the Serum Proteins and Leukocyte Formula in Subjects with Melanoma or other Types of Cancer

Richards, J.P., 1964:
Antibacterial Properties of Contact Lens Wetting and Storage Solutions

Bilai, V.I.; Pidoplichko, M.M.; Dymovich, V.O., 1964:
Antibacterial Properties of Penicillium L K. from the Rhizosphere of Agricultural Plants

Shorin, V.A.; Pevzner, N.S.; Shapovalova, S.P., 1963:
Antibacterial Properties of Ristomycin in Vitro and its Therapeutic Activity

Makeev, V.D., 1965:
Antibacterial Properties of the Tnt Preparation

Trefouel, J., 1964 :
Antibacterial Sulfonamides

Jaroszewicz, W., 1964:
Antibacterial Therapy as the Principal Factor in Controlling a Tuberculosis Epidemic

Juchniewicz, M.; Madey, J.; Stopczyk, J.; Zierski, M., 1964:
Antibacterial Therapy in the Plan for Tuberculosis Control in Poland

Martin, W.J., 1964:
Antibacterial Therapy. 3. Newer Observations on the Older Agents

Martin, W.J., 1964:
Antibacterial Therapy. I. Newer Agents Effective Against Penicillin G-Resistant Staphylococci--Newer Semi-Synthetic Penicillins

Martin, W.J., 1964:
Antibacterial Therapy. Ii. Newer Agents Having Effects other than Anti-Staphylococcal

Krukowska, H.; Paszkowska, A.; Kruszewska, W.; Zebrowska, H.; Meissner, J., 1965:
Antibacterial Treatment as a Factor in the Epidemiology and Control of Tuberculosis in Children

Lucchesi, M.; Bancale, A.; Rossi, P., 1963:
Antibacterial Treatment in Patients Afflicted with Pulmonary Tuberculosis Caused by Mycobacteria Resistant to the Major Chemo-Antibiotics

Skepian, N.A.; Luneva, O.K., 1964:
Antibacterial Treatment of Chronic Occupational Bronchitis

Volkova, L.V.; Kosareva, P.V.; Popov, V.F.; Timasheva, O.A., 2005:
Antibacterial acitivity of the peptide complex isolated from the preparation of leukocytic interferon

Ottaviano, G., 1962:
Antibacterial action and inhibitory action on the segmentation of the egg of Strongylocentrotus lividus of some amino-mercapto-benzene-sulfonamides

Francis, J.; Spinks, A., 1950:
Antibacterial action and metabolism of five sulphones

Costa, E.; Mattu, F.; Pani, M.L., 1951:
Antibacterial action in vitro of 6-6'dihydroxy-3,3,5,3',3', 5-hexamethyl-bis-1, 1'-spiro-hydrinene

Serembe, M., 1957:
Antibacterial action in vitro of cycloserine in discontinuous contact with human Mycobacterium tuberculosis

Bononi, L.J.; Jadevaia, V., 1962:
Antibacterial action in vivo of demethylchlorotetracycline

Bononi, L.J.; Jadevaia, V., 1962:
Antibacterial action in vivo of the tetracycline-oleandomycin combination (2:1 ratio)

Krejci, Z., 1952:
Antibacterial action of Canabis indica

Erdmann, G.R., 1987:
Antibacterial action of Myiasis-causing flies

Goeters, W.; Schlarb, E., 1956:
Antibacterial action of a combination of neomycin with bis-2-methyl-4-aminochinolyl-6-urea HCl in oral infections

Konowalchuk, J.; Clunie, J.C.; Hinton, N.A.; Reed, G.B., 1954:
Antibacterial action of a reaction product of cysteine and iron. II. Preparation and properties of the substance

Faggioli, G., 1952 :
Antibacterial action of a vitamin K simulant

Vasta, M.; Pessina, G., 1962:
Antibacterial action of alkyldimethylbenzylammonium chloride on B. anthracis. I. Influence of temperature

Vasta, M.; Pessina, G., 1962:
Antibacterial action of alkyldimethylbenzylammonium chloride on B. anthracis. II. Antibacterial power in the presence of blood serum

Cordova Marquez, R.; Axtmayer, J.H.; Brenes Pomales, A., 1954:
Antibacterial action of an extract from the jagua fruit, Genipa americana; preliminary note

Benigno, P.; Berti, T., 1951:
Antibacterial action of anionic detergents

Novak, M.; Taylor, W.I., 1951:
Antibacterial action of boric acid in lacrima (tears)

Benigno, P.; Berti, T., 1953:
Antibacterial action of cetyltrimethylammonium bromide on Escherichia coli: influence of brief contact

De Caro, M.; Scanga, F., 1954:
Antibacterial action of erythromycin

Seppilli, A.; Candeli, A.; Tarozzi, G., 1955:
Antibacterial action of floors treated with vinyl acetate

Zil'ber, L.A.; Solov'eva, I.V.; Volina, E.V.; Kravchenko, N.A., 1953:
Antibacterial action of hemin and of its derivatives

Ruiz Sanchez, F.; Ruiz Sanchez, A.; Naranjo Granda, E.; Ortegon, G., 1959:
Antibacterial action of kanamycin

Grivaux, M., 1950:
Antibacterial action of neomycin and furadroxyl in vitro and in vivo

Williams, J.A.; Pearson, G.J.; Colles, M.John., 2005:
Antibacterial action of photoactivated disinfection {PAD} used on endodontic bacteria in planktonic suspension and in artificial and human root canals

Gialdi, F.; Ponci, R., 1957:
Antibacterial action of quinoline derivatives. XII. In vitro activity of a series of aliphatic ethers of 8-mercaptoquinoline

Serembe, M., 1957:
Antibacterial action of racemic levo- and dextrorotatory cycloserine and of its synthetic intermediate products

Semenitz, E.; Bretschneider, H.; Rogenhofer, H., 1958:
Antibacterial action of some 4-substituted derivatives of 1, 3-dihydroxy-2-naphthoic acid

Fuller, A.T., 1947:
Antibacterial action of some aromatic amines, amidines, amidoximes, guanidines and diguanidines

Kanai, K.; Yanagisawa, K., 1955:
Antibacterial action of streptomycin against tubercle bacilli of various growth phases

Candeli, A., 1954:
Antibacterial action of various dentrifice components

Ienistea, C.; Ascher-Solomon, E., 1955:
Antibacterial action of yoghurt

Ghione, M.; Buogo, A.; Zavaglio, V., 1962:
Antibacterial actions experimental therapeutics with new penicillins

Sun, C.Q.; O'Connor, C.J.; Roberton, A.M., 2003:
Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori

Kazuno, T.; Fukushima, T.; Hayakawa, T.; Inoue, Y.; Ogura, R.; Kaminishi, H.; Miyazaki, K., 2005:
Antibacterial activities and bonding of MMSA/TBB resin containing amphiphilic lipids

Saeed, S.; Tariq, P., 2007:
Antibacterial activities of Emblica officinalis and Coriandrum sativum against Gram negative urinary pathogens

Ozer, F.; Unlü, N.; Karakaya, S.; Ergani, O.; Hadimli, H.H., 2005:
Antibacterial activities of MDPB and fluoride in dentin bonding agents

Hara, T.; Araake, M.; Watabe, H., 2003:
Antibacterial activities of fosfomycin against several fresh clinical isolates--comparison of the test methods for antibacterial activity

Gialdi, F.; Ponci, R., 1957:
Antibacterial activities of quinoline derivatives. XI. Preparation of a series of alkyl, hydroxyalkyl, and aminoalkyl-8-quinoline sulfides

Collier, H.O.; Potter, M.D.; Taylor, E.P., 1953:
Antibacterial activities of some bisisoquinolinium salts

Siddqiui, S.; Shyum, S.B.; Usmanghani, K.; Shameel, M., 1993:
Antibacterial activity and Fatty Acid composition of the extract from hypnea musciformis (gigartinales, rhodophyta)

Imazato, S.; Kinomoto, Y.; Tarumi, H.; Ebisu, S.; Tay, F.R., 2003:
Antibacterial activity and bonding characteristics of an adhesive resin containing antibacterial monomer MDPB

Gao, X.; Lu, X-feng.; Li, S-fu.; Gao, K.; Cheng, J-qiu., 2005:
Antibacterial activity and cytotoxicity of polypeptide dhvar4

Müller, G.; Winkler, Y.; Kramer, A., 2003:
Antibacterial activity and endotoxin-binding capacity of Actisorb Silver 220

Santarato, R., 1951:
Antibacterial activity and inactivation of chloramphenicol in regard to a resistant strain of Escherichia coli selected rapidly and slowly

Malatesta, P.; Scuro, L.A.; Sorice, F., 1950:
Antibacterial activity and mechanism of action of triiodotriethylamine

Di Marco, A.; Ciceri, C.; Zavaglio, V., 1951:
Antibacterial activity and pharmacological properties of streptomycin-PAS salt

Ericksen, B.; Wu, Z.; Lu, W.; Lehrer, R.I., 2004:
Antibacterial activity and specificity of the six human {alpha}-defensins

Silva, M.Garcia.; Furtado, N.Araçari.Jacometti.Cardoso.; Pupo, Mônica.Tallarico.; Fonseca, M.José.Vieira.; Said, S.; da Silva Filho, A.Alves.; Bastos, J.Kenupp., 2005:
Antibacterial activity from Penicillium corylophilum Dierckx

Saify, Z.S.; Farhad, J.; Mushtaq, N.; Noor, F.; Akhtar, S.; Arif, M.; Naqvi, B.Shyum.; Shoaib, M.Harris., 2005:
Antibacterial activity of 1-methyl-7-methoxy-beta-carboline and its phenacyl and coumarine analogues

Ercan, Eğrul.; Ozekinci, T.; Atakul, F.; Gül, K., 2004:
Antibacterial activity of 2% chlorhexidine gluconate and 5.25% sodium hypochlorite in infected root canal: in vivo study

Mazzacca, G.; Altucci, P.; Talarico, L., 1959:
Antibacterial activity of 2-chloroethyl-methanesulfonate and 2-fluoroethyl-methanesulfonate

Du, P.; Zhu, S.; Lü, P., 2003:
Antibacterial activity of 20 kinds of Chinese medicinal materials for Helicobacter pylori in vitro

Enesco, M., 1951:
Antibacterial activity of 4,4' diamino 2,2' dihydroxydiphenylsulfone

Morita, M.; Tanji, Y.; Mizoguchi, K.; Soejima, A.; Orito, Y.; Unno, H., 2005:
Antibacterial activity of Bacillus amyloliquefaciens phage endolysin without holin conjugation

Kotigadde, S.; Jose, S.; Zachariah, A.; Premanathan, P.; Bhat, K.GopalaKrishna., 2006:
Antibacterial activity of Bridelia scandens

Youngken, H.W.; Walsh, R.A., 1954:
Antibacterial activity of Cassia reticulata Willd

Qin, Q.; Xie, Z-xia.; Pi, H-zhen., 2003:
Antibacterial activity of Chinese medicine kou-kang mouthwash and its acute toxicity test

Tominaga, K.; Higuchi, K.; Hamasaki, N.; Tanigawa, T.; Sasaki, E.; Watanabe, T.; Fujiwara, Y.; Oshitani, N.; Arakawa, T.; Ishii, E.; Tezuka, Y.; Nagaoka, T.; Kadota, S., 2005:
Antibacterial activity of a Chinese herbal medicine, Gosyuyu (Wu-Chu-Yu), against Helicobacter pylori

German, A.; Panouse-Perrin, J., 1963:
Antibacterial activity of a new antibiotic, penimepicycline

Bodrumlu, E.; Semiz, M., 2006:
Antibacterial activity of a new endodontic sealer against Enterococcus faecalis

Anigstein, L.; Whitney, D.M.; Micks, D.W., 1950:
Antibacterial activity of a substance present in ticks (Ixodoidea) of Texas

Di Marco, A.; Zavaglio, V., 1951:
Antibacterial activity of a tensioactive diguanidine derivative

Malatesta, P.; Scuro, L.A.; Sorice, F., 1951:
Antibacterial activity of aliphatic halogen derivatives, particularly chloropicrin and bromopicrin; contribution to the study of their mechanism of action

Han, G.K.; Warsa, R., 1958:
Antibacterial activity of allantoic fluid of embryonated eggs infected with influenza virus against Bacillus subtilis

Sakagami, Y.; Iinuma, M.; Piyasena, K.G.N.P.; Dharmaratne, H.R.W., 2005:
Antibacterial activity of alpha-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics

Ndukwe, K.Chioma.; Okeke, I.N.; Lamikanra, A.; Adesina, S.K.; Aboderin, O., 2005:
Antibacterial activity of aqueous extracts of selected chewing sticks

Faustova, N.M.; Faustova, M.E.; Deĭneko, I.P., 2006:
Antibacterial activity of aspen bark extracts against some pneumotropic microorganisms

Bozzo, A.; Pino, G., 1950:
Antibacterial activity of aureomycin and of chloromycetin in cerebrospinal fluid

Badawy, O.F.H.; Shafii, S.S.A.; Tharwat, E.E.; Kamal, A.M., 2005:
Antibacterial activity of bee honey and its therapeutic usefulness against Escherichia coli O157:H7 and Salmonella typhimurium infection

Candeli, A., 1949 :
Antibacterial activity of bromide derivatives of fluorescein mercury oxide

Zerman, A.M.; Andolfatto-Zaglia, G., 1957:
Antibacterial activity of bromsulphalein

Watanabe, A.; Tokue, Y.; Kikuchi, T.; Gomi, K.; Aoki, S.; Satoh, T.; Fujimura, S., 2005:
Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004

Abe, T.; Fukuoka, T.; Sato, Y.; Ito, K.; Sei, M., 2003:
Antibacterial activity of cefpodoxime against clinical isolates in 2000 and 2001

Spasov, A.; Golovinski, E.; Markov, K.I., 1960:
Antibacterial activity of certain thioamides of picolinic acid

Mai-Ngam, K.; Chumningan, P., 2004:
Antibacterial activity of chitosan under physiological conditions

Islam, S.N.; Ferdous, A.J.; Ahsan, M.; Faroque, A.B., 1990:
Antibacterial activity of clove extracts against phagogenic strains including clinically resistant isolates of Shigella and Vibrio cholerae

Di Marco, A.; Boretti, G.; Fuoco, L.; Zavaglio, V., 1951:
Antibacterial activity of complex sulfones compared to that of diaminodiphenylsulfone

Di Marco, A.; Boretti, G.; Fuoco, L.; Zavaglio, V., 1951:
Antibacterial activity of complex sulfones in comparison with that of diamino-diphenyl-sulfone

Arakawa, K., 1953:
Antibacterial activity of compounds possessing a tricarbonylmethane group. X. Observations on the acetylation of 4-hydroxycoumarin and synthesis of 3-(alpha-aminophenylacetyl)-4-hydroxycoumarins

Ukita, T.; Arakawa, K., 1957:
Antibacterial activity of compounds possessing a tricarbonylmethane group. XI. Synthesis of a compound having structure analogous to A-ring of tetracycline

Akgul, C.; Saglikoglu, G., 2006:
Antibacterial activity of crude methanolic extract and its fractions of aerial parts of Anthemis tinctoria

Gialdi, F.; Ponci, R., 1950:
Antibacterial activity of derivatives of quinoline. Note I. Antibacterial activity in vitro of some esters of quinoline-6-carbonic acid

Gialdi, F.; Ponci, R., 1951:
Antibacterial activity of derivatives of quinoline. VI. Preparation of some Schiff bases from quinoline-8-aldehyde

Caramia, F.; Ricci, A., 1961:
Antibacterial activity of derivatives of styrene. II

Başeren, M.; Yazici, A.Rüya.; Ozalp, M.; Dayangaç, B., 2005:
Antibacterial activity of different generation dentin-bonding systems

Colombo Corti, I., 1962:
Antibacterial activity of diphenhydramine HCI

Uchin, R.A.; Parris, L., 1963:
Antibacterial activity of endodontic medications after varying time intervals within the root canal

Pessini, G.Lorena.; Dias Filho, B.Prado.; Nakamura, C.Vataru.; Cortez, Dógenes.Aparício.Garcia., 2004:
Antibacterial activity of extracts and neolignans from Piper regnellii (Miq.) C. DC. var. pallescens (C. DC.) Yunck

Matsuzaki, K.; Watabe, E.; Yoshimori, K.; Shikano, M.; Sato, Y.; Hasegawa, M.; Kobayashi, I., 2003 :
Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002

Ginalska, G.; Osinska, M.; Uryniak, A.; Urbanik-Sypniewska, T.; Belcarz, A.; Rzeski, W.; Wolski, A., 2005:
Antibacterial activity of gentamicin-bonded gelatin-sealed polyethylene terephthalate vascular prostheses

Pinheiro, Sérgio.Luiz.; Simionato, M.Regina.Lorenzetti.; Imparato, Jé.Carlos.Pettorossi.; Oda, M., 2005:
Antibacterial activity of glass-ionomer cement containing antibiotics on caries lesion microorganisms

Hebling, J., 2006:
Antibacterial activity of glass-ionomer cements

Vermeersch, G.; Leloup, G.; Delmée, M.; Vreven, J., 2005:
Antibacterial activity of glass-ionomer cements, compomers and resin composites: relationship between acidity and material setting phase

Cosquer, A.; Ficamos, M.; Jebbar, M.; Corbel, J-Charles.; Choquet, Génaëlle.; Fontenelle, C.; Uriac, P.; Bernard, Téophile., 2004:
Antibacterial activity of glycine betaine analogues: involvement of osmoporters

Funatogawa, K.; Hayashi, S.; Shimomura, H.; Yoshida, T.; Hatano, T.; Ito, H.; Hirai, Y., 2004:
Antibacterial activity of hydrolyzable tannins derived from medicinal plants against Helicobacter pylori

Lewis, M.N.; Schwartz, B.S., 1949:
Antibacterial activity of liver extracts against beta-hemolytic streptococcus

Walter, G.R.; Gump, W.S., 1962:
Antibacterial activity of mixtures of quaternary ammonium compounds and hexachlorophene

Kopacz, M.; Woźnicka, E.; Gruszecka, J., 2005:
Antibacterial activity of morin and its complexes with La(III), Gd(III) and Lu(III) ions